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Abstract 
 
Synaptic plasticity is the ability of neuronal connections to change in strength. 
Long lasting modifications of synaptic strength, such as long term potentiation (LTP), are 
considered as the cellular mechanism mediating learning and memory. 
Synaptic transmission has been classically considered as a plot with two actors: 
the presynaptic neuron carrying the message and the postsynaptic neuron receiving 
and integrating it. Although a circuit composed of these two elements is the minimal 
requirement for synaptic communication, also glia cells, and in particular astrocytes, 
play important roles not only in sustaining neural function but also in actively shaping 
synaptic transmission and plasticity. For example, astrocytes detect glutamate 
released from the presynaptic terminal and respond to this stimulus with the release of 
molecules that modulate the activity of both pre- and postsynaptic compartments. 
Moreover, astrocytes regulate synaptic glutamate concentration through uptake of 
extracellular glutamate by specific glutamate transporters. The molecular mechanisms 
regulating neuro-glia communication are not fully understood. 
Eph receptor tyrosine kinases and their ephrin ligands are critical modulators of 
synaptic plasticity. It has been shown that the EphA4 receptor promotes long term 
plasticity at the CA3-CA1 synapse in the hippocampus independently of its 
cytoplasmic domain. However, it was not known which specific synaptic compartment 
requires EphA4, or which molecular mechanisms mediate its action. By removing EphA4 
from pre- or postsynaptic neurons, I now show that only postsynaptic EphA4 is required 
for LTP modulation. 
EphrinA3 is a high affinity ligand for EphA4 expressed in astrocytes. Here I 
demonstrate that Efna3 null mutants also have impaired LTP, raising the possibility that 
EphA4 function involves astrocytes. Interestingly, both Epha4 and Efna3 null mutant 
mice show increased expression of glial glutamate transporters and glutamate uptake 
is enhanced in astrocytes lacking ephrinA3. The LTP deficit observed in Epha4 and 
Efna3 mutants is rescued by applying glutamate transporter inhibitors, providing a 
direct link between the altered glial glutamate transporter expression and LTP 
deficiency. In a gain-of-function experiment, transgenic mice overexpressing ephrinA3 
                                                                                     Abstract 
 
 
2 
 
specifically in astrocytes presented a reduction in glial glutamate transporter 
expression. Moreover, overexpression of ephrinA3 in astrocytes caused glutamate 
excitotoxicity and increases susceptibility to seizures in vivo.  
Taken together, these results suggest that the interaction between dendritic 
EphA4 and astrocytic ephrinA3 modulates long term synaptic plasticity by negatively 
regulating the expression of glial glutamate transporters and consequently controlling 
glutamate concentration near synapses. On the other hand, increased activation of 
EphA4-ephrinA3 signaling leads to pathological conditions caused by enhanced 
glutamatergic transmission. 
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Zusammenfassung 
 
Als synaptische Plastizität bezeichnet man die Fähigkeit neuronaler 
Verbindungen, ihre Übertragungsstärke zu verändern. Lang anhaltende 
Veränderungen der synaptischen Übertragungsstärke, wie z.B. Langzeit-Potenzierung 
(LTP), werden als die zellulären Mechanismen angesehen, die Lernen und Gedächtnis 
vermitteln. 
Synaptische Plastizität wurde klassischerweise als ein Vorgang mit zwei 
Akteuren angesehen: Das präsynaptische Neuron, das die Information trägt und das 
postsynaptische Neuron, welches die Information empfängt und weiterverarbeitet. 
Obwohl ein Schaltkreis aus diesen beiden Elementen die kleinstmögliche Einheit für 
synaptische Kommunikation ist, spielen auch Gliazellen, vor allem Astrozyten, eine 
wichtige Rolle, nicht nur bei der Aufrechterhaltung neuronaler Funktion. Sie sind auch 
aktiv an der Gestaltung der von neuronaler Transmission und synaptischer Plastizität 
beteiligt. Astrozyten können zum Beispiel von der präsynaptischen Endigung 
freigesetztes Glutamat erkennen und auf diesen Stimulus mit der Freisetzung von 
Molekülen reagieren, welche die prä- und postsynaptische Aktivität regulieren. 
Ausserdem regulieren Astrozyten die synaptische Glutamatkonzentration über die 
Aufnahme extrazellulären Glutamats mithilfe spezifischer Glutamattransporter. Die 
molekularen Mechanismen, welche Neuron-Glia Interaktionen regulieren, sind noch 
nicht vollständig verstanden. 
Eph Rezeptor Tyrosin Kinasen und ihre Ephrin Liganden sind entscheidende 
Regulatoren synaptischer Plastizität. Es konnte gezeigt werden, dass der EphA4 
Rezeptor unabhängig von seiner cytoplasmischen Domäne an der Langzeitplastizität 
an der CA3-CA1 Synapse im Hippocampus beteiligt ist. Allerdings war weder 
bekannt, welches spezifische synaptische Kompartiment hierbei EphA4 benötigt, noch 
welche molekularen Mechanismen diese Funktion vermitteln. Durch Entfernen von EphA4 
aus den prä- und postsynaptischen Zellen konnte ich jetzt zeigen, dass nur 
postsynaptisches EphA4  nötig ist, um LTP zu modulieren. 
EphrinA3 ist ein hochaffiner Ligand für EphA4 und ist in Astrozyten exprimiert. 
Ich zeige hier, dass Efna3 null Mutanten auch eine Beeinträchtigung im LTP haben, was 
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die Möglichkeit nahelegt, dass die Funktion von EphA4 auch Astrozyten umfasst. 
Interessanterweise zeigen sowohl Epha4 als auch Efna3 knock out Mäuse erhöhte 
Expression des glialen Glutamattransporters und Astrozyten, welchen ephrinA3 fehlt, 
zeigen eine gesteigerte Glutamataufnahme. Das in Epha4 und Efna3 Mutanten 
beobachtete LTP Defizit kann durch die Zugabe von Glutamattransporterinhibitoren 
verhindert werden, was eine direkte Verbindung zwischen veränderter Expression von 
Glutamattransportern in Gliazellen und Fehlen von LTP aufzeigt. In einem gain-of-
function Experiment zeigten Mäuse, die ephrinA3 spezifisch in Astrozyten 
überexprimieren, reduzierte Expression des glialen Glutamattransporters. Des 
Weiteren führte die Überexpression von ephrinA3 in Astrozyten zu Excitotoxizität und 
einer erhöhten Neigung zu Krämpfen in vivo. 
Zusammengenommen legen diese Ergebnisse nahe, dass die Interaktion 
zwischen dendritischem EphA4 und ephrinA3  in Astrozyten durch die negative 
Regulation des glialen Glutamattransporters und die daraus folgende Kontrolle der 
Glutamatkonzentration in der Nähe der Synapsen die synaptische Langzeitplastizität 
moduliert. Andererseits führt die erhöhte Aktivierung von EphA4-ephrinA3 
Signaltransduktion zu pathologischen Veränderungen, verursacht durch verstärkte 
glutamaterge Neurotransmission. 
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1.1 Anatomy of the hippocampus 
 
The hippocampus is a structure in the brain of vertebrates involved in spatial 
navigation and certain types of learning and memory (Andersen, 2007; O'Keefe 
and Nadel, 1978). The hippocampal region that includes cornu ammonis (CA) 
fields, dentate gyrus and subiculum together with the adjacent entorhinal, perirhinal 
and parahippocampal cortices constitute the medial temporal lobe (Squire et al., 
2004). 
The mammalian hippocampus is a three-layered structure, also known as 
archicortex, with a central layer of densely packed neuronal somata that lies 
between two relatively cell-sparse layers (figure 1.1). The layers of the dentate 
gyrus are termed molecular layer (stratum moleculare), granule cell layer and 
polymorphic layer (also known as hilus). The cytoarchitectonics of CA3 and CA1 is 
more complex and five to six layers can be recognized. They are termed, from 
deep to superficial, stratum lacunosum-moleculare, stratum radiatum, stratum lucidum 
(present only in CA3), stratum pyramidale, stratum oriens and stratum alveus. The 
subiculum is an even more complex structure, with different areas with four or five 
cell body layers, because it is a transition region between the three-layered 
archicortex and the six-layered entorhinal cortex. 
The major inputs to the hippocampus are carried by axons of the perforant 
path, which connect neurons in layer II of the entorhinal cortex to granule cells in the 
dentate gyrus. In addition, layer III cells of the entorhinal cortex are connected to 
the distal apical dendrites of CA1 pyramidal cells in the stratum lacunosum-
moleculare. Granule cells project their axons (mossy fibers) to the apical dendrites 
of CA3 pyramidal cells which, in turn, are connected to the apical dendrites of CA1 
pyramidal cells in the stratum radiatum, and to a minor extent with basal dendrites 
of stratum oriens, through Schaffer collaterals. In addition, CA3 neurons project to 
controlateral CA3 and CA1 pyramidal cells through commissural connections and 
there is also an associative network connecting CA3 cells ipsilaterally. Finally, CA1 
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pyramidal neurons project their axons back to the entorhinal cortex both directly 
and indirectly via the subiculum. The circuit connecting entorhinal cortex and 
hippocampus is therefore a closed loop of glutamatergic excitatory synapses. The 
hippocampus receives also modulatory inputs from other brain regions including the 
septum, amygdala, thalamus, hypothalamus and brainstem monoaminergic nuclei. 
The activity of hippocampal circuits is controlled by a complex network of -
aminobutyric acid (GABA)-releasing interneurons (Klausberger and Somogyi, 
2008). 
Because of its well characterized and relatively simple circuitry, the 
hippocampus offers many advantages for electrophysiological analysis and has 
provided important details about the mechanisms underlying synaptic transmission 
and plasticity.  
Figure 1.1 Anatomy of the mouse hippocampus. Transversal section of an adult mouse 
hippocampus showing the layer organization and schematic representation of the main internal 
and external axonal pathways. Abbreviations: CA1, cornus ammonis 1; CA3, cornus ammonis 
3; DG, dentate gyrus; lac.-mol, lacunosum-moleculare; Str., stratum. 
_____________________________________________________________________ 
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1.2 Structural and functional properties of hippocampal synapses 
 
Synapses are specialized intercellular junctions between neurons or between 
neurons and other excitable cells where signals are transmitted from one cell to 
another (Cowan et al., 2001). Electrical synapses are gap junctions that allow the 
propagation of electrical signals through connected cells. At chemical synapses 
electrical signals carried by the axon induce release of molecules 
(neurotransmitters) from the presynaptic terminal into the synaptic cleft. This 
chemical signal is then reconverted postsynaptically into an electrical signal through 
binding of neurotransmitters to specific receptors. In vertebrates most of the 
synapses are chemical. Electrical synapses do not allow significant modulation of 
signal propagation. On the contrary, chemical synapses, hereafter referred to 
simply as synapses, are flexible in morphology and function and finely tune the 
information flow between neurons (Cowan et al., 2001). Synapses of different 
regions of the central nervous system (CNS) share some common basic features. 
However, neuronal connections in different neural circuits also have structural and 
physiological differences. For this reason the following description will focus on the 
characteristics of the excitatory Schaffer collateral synapse in the hippocampus 
(hereafter referred to as CA3-CA1 synapse). 
 
1.2.1 Presynaptic compartment and mechanism of neurotransmitter release 
 
Schaffer collateral fibers from CA3 pyramidal neurons make en passant 
(non-terminal) synapses on CA1 pyramidal neuron dendrites. For this reason these 
axons contact many neurons along their path in the stratum radiatum of CA1. 
Presynaptic boutons appear as axonal expansions containing mitochondria, 
endosomal membranes and synaptic vesicles filled with glutamate (figure 1.2). 
Synaptic vesicles are distributed in two distinct pools; those situated more distally 
from the synaptic junction are part of a reserve pool while others found in direct 
contact with the presynaptic cell membrane in an area known as active zone 
                                                                              1 Introduction 
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Figure 1.2 Morphology and main molecular components of the CA3-CA1 
synapse. a) Electron microscopy image of a synapse between a CA3 neuron axon 
and a CA1 pyramidal cell dendrite. The presynaptic bouton filled with synaptic 
vesicles (SV) and the dendritic spine with the electron dense postsynaptic density 
(PSD) are visible. Scale bar 0.5 m. b) Schematic representation of a CA3-CA1 
synapse with some of the proteins required for neuronal transmission and plasticity. 
VGCC, voltage-gated calcium channel; SM, Sec1/Munc18-like proteins. Figure 
1.2a is modified from (Sheng and Hoogenraad, 2007). 
____________________________________________________________ 
belong to the readily releasable pool (Murthy and De Camilli, 2003). The release 
of synaptic vesicles is a highly regulated process involving a complex molecular 
machinery triggered by calcium influx through voltage-gated calcium channels 
during axonal depolarization (Murthy and De Camilli, 2003; Sudhof, 2004). The 
synaptic vesicle release process can be divided in different steps. First, synaptic 
vesicles have to be attached to the active zone through the formation of a docking 
complex between the synaptic vesicle and plasma membrane proteins called 
vesicle (v) and target (t) SNAREs (SNAP(S-nitroso-N-acetylpenicillamine) receptors). 
Synaptic exocytosis is mediated by one v-SNARE (synaptobrevin/VAMP (vesicle-
associated membrane protein)) and two t-SNAREs on the presynaptic plasma 
membrane (syntaxin 1 and SNAP-25). It has been proposed that the SNARE 
complex creates an unstable membrane fusion intermediate without opening the 
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fusion pore. The SNARE complex formation is regulated by other players including 
complexins and Sec1/Munc18-like (SM) proteins. The next step is the exocytosis of 
synaptic vesicles triggered by the detection of calcium influx into the presynaptic 
bouton by the vesicle-associated proteins synaptotagmins through a mechanism not 
fully understood. After exocytosis, synaptic vesicles undergo endocytosis, recycle 
and refill with glutamate for a new round of exocytosis. 
 
1.2.2 Postsynaptic compartment  
 
Opposite to the axonal bouton is the postsynaptic reception apparatus that 
in the hippocampal glutamatergic synapse is located in small thorny-like protrusions 
of dendrites enriched in actin called spines (figure 1.2) (Bourne and Harris, 2008; 
Nimchinsky et al., 2002). Dendritic spines provide biochemical 
compartmentalization that allows local control of individual synapses. The distal tip 
of the spine contains a dense network of proteins termed postsynaptic density (PSD) 
juxtaposed to the presynaptic active zone (Sheng and Hoogenraad, 2007). The 
main function of the PSD is to anchor glutamate receptors at the postsynaptic 
plasma membrane and to ensure that the proper signaling cascade is started 
following receptor activation. 
 
1.2.2.1 Glutamate receptors  
 
Glutamate receptors can be ion channels (ionotropic receptors) or 
transmembrane proteins without intrinsic ion permeability coupled to intracellular 
signal transduction complexes (metabotropic receptors) (Cowan et al., 2001). Fast 
synaptic transmission at the CA3-CA1 synapse is mainly mediated by the ionotropic 
-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-methyl-D-
aspartate (NMDA) receptors. Metabotropic glutamate receptors (mGluRs) function 
as modulators that fine tune synaptic transmission.  
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AMPA receptors (AMPARs) are composed of four subunits (GluR1-4, also 
known as GluRA-D) (Shepherd and Huganir, 2007). Most AMPA receptors in 
hippocampal pyramidal neurons are GluR1-2 and GluR2-3 tetramers (Wenthold et 
al., 1996). At resting potential sodium influx accounts for most of the AMPAR 
current and is the main driving force for postsynaptic depolarization at the CA3-
CA1 synapse. However, also NMDA receptors (NMDARs) contribute significantly to 
synaptic transmission but in a more complex way. 
NMDARs exist as heteromultimers of two glycine-binding NR1 subunits and 
two glutamate-binding NR2A-D subunits. NR2C and D and two other subunits, 
NR3A and B, do not appear to play a relevant role in hippocampal pyramidal 
cells (Andersen, 2007). The subunit composition and compartmental localization of 
NMDARs are developmentally regulated and affect channel activity and 
downstream signaling (Cull-Candy and Leszkiewicz, 2004; Kohr, 2006). NR1 is the 
essential subunit of all NMDARs and can be assembled together with different NR2 
or NR3 subunits that determine the electrophysiological characteristics of the 
channel, affecting its conductance, opening time and magnesium sensitivity. In 
hippocampal pyramidal neurons NR2B is abundant at early developmental stages 
and NR2A progressively appears during postnatal development and plays a major 
role in adult hippocampal synapses. NR2A and NR2B appear to be preferentially 
localized in different subcellular compartments, with NR2A enriched in the PSD and 
NR2B mostly present in perisynaptic/extrasynaptic membranes (Janssen et al., 
2005). The NMDAR channel is doubly gated, opening only when two conditions are 
simultaneously satisfied: glutamate must be bound to the receptor and the 
postsynaptic membrane must be depolarized. The second condition is required for 
releasing the magnesium atom that blocks the channel at resting potential. This 
means that NMDARs are activated only when there is a conjunction of presynaptic 
glutamate release and postsynaptic depolarization. In this way NMDARs act as 
coincidence detectors of pre- and postsynaptic activity (Cull-Candy and 
Leszkiewicz, 2004; Kohr, 2006).  
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mGluRs contain seven transmembrane segments and are assembled as 
dimers. They are coupled to G proteins, which mediate most of their action (Anwyl, 
1999). mGluRs are divided in three classes based on differences in downstream 
signaling and pharmacological properties. Group I receptors tend to be localized 
in postsynaptic membranes in the perisynaptic compartment (Baude et al., 1993; 
Lujan et al., 1996). They activate phospholipase C (PLC) via G proteins, leading to 
an increase in inositol triphosphate and dyacilglycerol (Fagni et al., 2000). Group 
II and group III receptors are localized in presynaptic membranes and are 
negatively coupled to adenylate cyclase through G proteins (Anwyl, 1999). 
 
1.2.2.2 Scaffold and signaling proteins  
 
Glutamate receptors contain interaction domains in their cytoplasmic regions 
that allow them to contact intracellular scaffold and signaling proteins. Most of the 
scaffold proteins in the PSD contain PSD-95/DLG/ZO-1 (PDZ) domains, modular 
protein-interaction domains specialized for binding to short peptide motif at the 
carboxy termini of other proteins (Kim and Sheng, 2004). AMPARs, NMDARs and 
mGluRs contain such PDZ interacting motifs in their cytoplasmic domains that 
mediate binding to scaffold proteins such as PSD-95, glutamate receptor-
interacting proteins (GRIPs), guanylate kinase-associated protein (GKAP), Shank 
and Homer (figure 1.2) (Kim and Sheng, 2004; Sheng and Kim, 2002). These 
scaffold molecules, in turn, interact with cytoplasmic signaling proteins allowing the 
coupling of glutamate receptor activation to downstream signaling pathways. 
Different classes of proteins are engaged in signal transduction processes in the 
PSD, including kinases such as calcium-calmodulin-dependent protein kinase II 
(CaMKII), protein kinase A and C (PKA and PKC); phosphatases, such as calcineurin; 
and a plethora of other proteins that modulate the activity of kinases and 
phosphatases (Kennedy et al., 2005). Scaffold molecules not only interact with 
glutamate receptors but also, directly or indirectly, with other transmembrane 
proteins including receptor tyrosine kinases and adhesion molecules that coordinate 
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trans-synaptic communication and modulate postsynaptic function (Dalva et al., 
2007; Kim and Sheng, 2004). This complex network of proteins is responsible not 
only for mediating basal synaptic transmission, but also for triggering, maintaining 
and integrating experience-dependent changes in synaptic strength. 
 
1.3 Synaptic Plasticity 
 
Living organisms are embedded in an unpredictable environment and they 
must modify their behaviors accordingly to changes of their surroundings. For this 
reason evolution has favored strategies directed toward the development of 
flexible neural networks. Synaptic transmission can be modified by different 
patterns of neuronal activity, correlated with different environmental stimuli, 
through complex mechanisms collectively grouped under the name of synaptic 
plasticity (Kandel, 2001; Kim and Linden, 2007; Nelson and Turrigiano, 2008). 
Synaptic changes can last from some milliseconds to few minutes (short term 
plasticity) or can be maintained for days and possibly for the entire life of an 
organism (long term plasticity). Long lasting changes in synaptic strength associated 
with specific patterns of stimulation, such as long term potentiation (LTP) and long 
term depression (LTD), are considered as the cellular mechanisms responsible for 
the formation and storage of memories (Martin et al., 2000; Pastalkova et al., 
2006; Whitlock et al., 2006). These changes can also be associated with structural 
rearrangements such as gain or loss of synaptic connections and dendritic spine 
remodeling (Alvarez and Sabatini, 2007; Yuste and Bonhoeffer, 2001). The 
direction and amount of changes in synaptic strength are controlled by another 
process called metaplasticity (Abraham, 2008). Finally, the overall level of 
synaptic excitability is kept in a constant range by homeostatic synaptic scaling 
processes (Turrigiano, 2008). 
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1.3.1 Short term plasticity 
 
Short term forms of synaptic plasticity last at most few minutes and can be 
divided, on the basis of their duration, in facilitation or depression (few hundreds of 
milliseconds), augmentation (several tens of seconds) and post-tetanic potentiation 
(few tens of seconds to several minutes) (Zucker and Regehr, 2002). Facilitatory 
processes are usually attributed to a residual elevation of presynaptic 
concentration of calcium during brief trains of stimuli. However, other molecular 
events, including phosphorylation, could play a role especially in post-tetanic 
potentiation (Brager et al., 2003). Repeated stimulation of axons can induce 
synaptic enhancement or depression at different synapses depending on the 
intrinsic characteristics of the synapse. For example the amount of facilitation, also 
referred to as paired pulse facilitation (PPF), is inversely related to the initial 
release probability of the synapse (Dobrunz and Stevens, 1997). At synapses with 
high release probability depression prevails due to depletion of the pool of 
readily releasable vesicles. Depression can also be a consequence of feedback 
activation of presynaptic receptors and/or postsynaptic events such as glutamate 
receptor desensitization (Zucker and Regehr, 2002).  
 
1.3.2 Long term plasticity  
 
LTP and LTD can be triggered and expressed by a variety of different 
mechanisms at different synapses. In some synapses, such as the hippocampal 
mossy fiber-CA3 synapse, long term plasticity is expressed presynaptically, as a 
change of the probability of neurotransmitter release (Malenka and Bear, 2004; 
Nicoll and Schmitz, 2005). In other synapses, like the CA3-CA1 synapse, LTP and 
LTD are expressed as changes in number and unitary conductance of AMPARs 
and/or NMDARs (Malenka and Bear, 2004; Nicoll, 2003). Here I will focus on the 
mechanism of induction and expression of LTP and LTD at the CA3-CA1 synapse. 
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1.3.2.1 Long term potentiation 
 
Long lasting enhancement of synaptic strength can be induced at the CA3-
CA1 synapse by applying a train of stimuli at high frequency to Schaffer 
collaterals. Different stimulation patters can be used (Albensi et al., 2007). A 
commonly used LTP induction protocol consists of a single 100 Hz train of one 
second duration (tetanus, figure1.3). However, this kind of stimulation is probably 
different from naturally occurring firing patterns of hippocampal neurons (Albensi 
et al., 2007). For this reason other stimulation protocols, such as theta burst 
stimulation (TBS, figure 1.3), that resemble more closely the neuronal firing in the 
hippocampus during episodes of learning and memory were developed (Morgan 
and Teyler, 2001). Such stimulation patterns lead to calcium influx through NMDARs 
and to a rise in calcium concentration in dendritic spines.  This step is an absolute 
requirement for LTP induction at the CA3-CA1 synapse and pharmacological 
inhibition or genetic ablation of NMDARs prevents LTP (Malenka and Bear, 2004; 
Nicoll, 2003). On the other hand, overexpression of NMDARs enhances LTP (Tang 
et al., 1999). Calcium influx into the spine triggers a cascade of molecular events 
that result in potentiation of synaptic transmission. A plethora of proteins have been 
shown to be involved in LTP induction and/or expression. Some of them are 
absolutely required for LTP induction (mediators) while others can alter LTP but are 
not essential for its occurrence (modulators) (Malenka and Bear, 2004; Sanes and 
Figure 1.3 Stimulation patterns used for LTP induction. Schematic representation of a tetanus 
and theta burst stimulation (TBS) used in experiments described in this thesis. Three trains of 
TBS with intervals of 10 s were used. Each vertical line represents one electrical stimulus. 
_____________________________________________________________________ 
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Lichtman, 1999). An important mediator is CaMKII and genetic deletion of a crucial 
CaMKII subunit blocks the induction of LTP (Lisman et al., 2002; Silva et al., 1992). 
Several other kinases play key roles in LTP induction. PKA is required for LTP 
induction during early postnatal life but its action is less relevant in the adult 
(Malenka and Bear, 2004; Yasuda et al., 2003). Different isoforms of PKC, in 
particular the atypical isozyme protein kinase M zeta (PKM), are also important 
for LTP (Malenka and Bear, 2004; Pastalkova et al., 2006). Other important 
players are Src family kinases (Lu et al., 1998) and mitogen-activated protein 
kinases (MAPKs) (Thomas and Huganir, 2004). These enzymes phosphorylate 
different substrates in the postsynaptic compartment, including glutamate receptors. 
Phosphorylation of specific amino acids regulates the unitary conductance and 
surface expression of glutamate receptors (Salter and Kalia, 2004; Sheng and 
Kim, 2002; Shepherd and Huganir, 2007). A major mechanism for expression of 
LTP at the CA3-CA1 synapse involves the increase of surface expression of 
AMPARs (Shepherd and Huganir, 2007).  
Different phases of LTP can be distinguished based on their duration and 
molecular mechanisms required for their maintenance (Kelleher et al., 2004). While 
protein phosphorylation events can sustain LTP for circa one hour (early LTP), new 
mRNAs and proteins must be synthesized to sustain enhanced synaptic transmission 
for longer periods (late LTP). Late LTP initially needs translation of mRNAs, often 
stored locally in dendrites (Kelleher et al., 2004; Sutton and Schuman, 2006). After 
few more hours new mRNAs must be transcribed (Kelleher et al., 2004). This last 
phase involves signaling from the potentiated synapses to the cell nucleus through 
the action of kinases, such as PKA, CaMKIV and MAPKs, that converges on the key 
transcription factor cyclic AMP responsive element-binding protein (CREB) (Adams 
and Dudek, 2005; Flavell and Greenberg, 2008). CREB, in turn, initiates the 
transcription of mRNAs, such as the one coding for the activity regulated 
cytoskeletal-associated protein (Arc), and consequently the production of new 
proteins that must be transported back specifically to potentiated synapses through 
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a mechanism that probably requires the presence of a “synaptic tag” applied to 
synapses after LTP induction (Martin and Kosik, 2002).  
 
1.3.2.2 Long term depression 
 
Prolonged low frequency (0.5-5 Hz) stimulation of Schaffer collaterals 
induces long lasting depression of synaptic transmission in CA1 pyramidal cells 
(Dudek and Bear, 1992). Two distinct forms of LTD coexist at the CA3-CA1 
synapse, one triggered by activation of NMDARs (NMDAR-LTD) and another one 
requiring signaling downstream of group I mGluRs (mGluR-LTD) (Malenka and 
Bear, 2004; Oliet et al., 1997).  
NMDAR-LTD is induced by influx of calcium through NMDARs during low 
frequency stimulation. The quantitative and temporal characteristics of the calcium 
influx determine direction of synaptic changes, with fast calcium entry leading to 
LTP and slower and more prolonged influx triggering LTD (Bi and Poo, 2001; 
Sheng and Kim, 2002). LTD is correlated with dephosphorylation of postsynaptic 
PKA and PKC, but not CaMKII, substrates (Malenka and Bear, 2004). Important 
phosphatases involved in this process are calcineurin and protein phosphatase 1 
(PP1) (Sheng and Kim, 2002). Dephosphorylation events are accompanied by 
decreased AMPAR open channel probability and reduced AMPAR surface 
expression (Shepherd and Huganir, 2007). 
mGluR-LTD can be induced in presence of NMDAR inhibitors (Oliet et al., 
1997). Like NMDAR-LTD, it also requires rise in postsynaptic calcium but T-type 
calcium channels are involved instead of NMDARs (Oliet et al., 1997). PKC 
activation is involved in mGluR-LTD while phosphatase activity is dispensable (Oliet 
et al., 1997). Similarly to NMDAR-LTD, mGluR-LTP induction triggers internalization 
of postsynaptic AMPARs (Malenka and Bear, 2004; Snyder et al., 2001). 
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1.3.3 Structural plasticity 
 
Patterns of neuronal activity that induce long term synaptic plasticity can 
also trigger changes in dendritic spine morphology (Alvarez and Sabatini, 2007; 
Yuste and Bonhoeffer, 2001). Induction of LTP is associated with the growth of new 
spines (Engert and Bonhoeffer, 1999) and persistent volume increase of the existing 
ones (Matsuzaki et al., 2004). On the other hand, stimulation protocols that trigger 
LTD induce spine retraction (Nagerl et al., 2004). Structural changes of neuronal 
connections have been observed also in vivo. Sensory deprivation increases spine 
motility in the primary visual and somatosensory cortices in rodents (Hofer et al., 
2009; Majewska et al., 2006; Zuo et al., 2005), and environmental enrichment 
increases dendritic branching, spine density and number of synapses in rodents 
(Alvarez and Sabatini, 2007) and primates (Kozorovitskiy et al., 2005). 
Remodeling of the actin cytoskeleton is responsible for structural changes 
associated with synaptic plasticity (Bourne and Harris, 2008). 
 
1.3.4 Metaplasticity 
 
The capability of neurons to generate changes of synaptic strength and the 
quantitative control of these changes is affected by prior patterns of synaptic 
activity through modulatory mechanisms collectively termed metaplasticity 
(Abraham, 2008; Abraham and Bear, 1996). The difference between 
metaplasticity and other forms of synaptic modulation is that while the latter 
overlap in time with the regulated event, the former can persist for prolonged 
periods after priming signal. Events capable of inducing metaplastic changes 
include specific patterns of electrical stimulation, pharmacological activation of 
neurotransmitter receptors, release of hormones and sensory deprivation 
(Abraham, 2008). The major consequence of the priming activity is modification of 
the thresholds for induction of LTP and LTD, without itself causing persistent synaptic 
plasticity. For example, in the visual cortex of light-deprived rats the threshold for 
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induction of LTP is reduced while the one for LTD is increased as a consequence of 
reduced synaptic activity (Kirkwood et al., 1996). One of the mechanisms 
mediating metaplastic effects involves modification of the intrinsic excitability of 
neurons, for example through modifications of voltage-gated potassium channels 
(Chen et al., 2006; Kim and Linden, 2007). Metaplasticity can be considered as a 
homeostatic mechanism that preserves stability in the network and prevents 
runaway potentiation or depression (Abraham, 2008). 
 
1.3.5 Homeostatic synaptic scaling  
 
The global activity of neural networks has to be tightly controlled and kept 
within a particular range otherwise processes like LTP and LTD could drive synapses 
to their limits of potentiation and depression, respectively. Metaplasticity represents 
a mechanism to achieve this objective. Another way is through homeostatic synaptic 
scaling, a processes employed by neurons to adjust their own firing rate depending 
on the overall activity of the network (Turrigiano, 2008; Turrigiano and Nelson, 
2004). Neurons tend to increase their firing rate in response to prolonged inhibition 
of synaptic transmission, for example in presence of tetrodotoxin, while they 
compensate in the opposite direction when network activity is increased, for 
example in presence of the GABAA receptor inhibitor picrotoxin. Homeostatic 
synaptic scaling takes place not only in vitro but also in vivo (Goel and Lee, 2007; 
Maffei et al., 2004) and without this form of plasticity neural networks can become 
unstable and perform suboptimally (Abbott and Nelson, 2000; Turrigiano and 
Nelson, 2004). 
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Figure 1.4 Astrocyte-mediated modulation of synaptic 
function. Scheme summarizing some of the mechanisms 
used by astrocytes to regulate synaptic transmission and 
plasticity. Binding of glutamate to receptors present on 
astrocytic processes (orange) induces increase of 
intracellular calcium that, in turn, triggers release of 
gliotransmitters. Astrocytes control extracellular 
concentration of glutamate and potassium through specific 
transporters and channels. Molecules released by 
astrocytes promote synaptogenesis. 
___________________________________________ 
1.4 Contributions of glia to synaptic transmission and plasticity 
 
The volume of mammalian brains is mostly occupied by nonneuronal cells 
called glia. During evolution the density and morphology of these cells have 
remarkably increased (Kettenmann and Verkhratsky, 2008; Sherwood et al., 
2006). Glial cells in the mature CNS are commonly divided in three major families: 
oligodendrocytes, astrocytes and microglia (Barres, 2008). A new class of glia, the 
NG2-glia or 
polydendrocytes, which has 
some neuronal features and 
receives synaptic inputs, has 
been recently described 
(Nishiyama et al., 2009). 
The main function of 
oligodendrocytes is to wrap 
axons with myelin allowing 
fast impulse conduction and 
to support axon functional 
integrity (Nave and Trapp, 
2008). Microglia are the 
resident immune cells of the 
brain and share many 
properties with 
macrophages (Soulet and 
Rivest, 2008). Astrocytes 
play many roles in brain 
physiology and they will be 
the focus of this introduction. 
For a long time glial 
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cells have been regarded as passive bystanders with the only function of providing 
trophic support to neurons (Kettenmann and Verkhratsky, 2008). For example, 
astrocytes are responsible for homeostatic and trophic regulation of the CNS by 
affecting extracellular concentration of ions, water movements, blood brain barrier 
function and supply of energetic substrates for neurons (Hertz and Zielke, 2004). 
However, glial cells, and in particular astrocytes, can also actively modulate 
synaptic function by controlling the genesis and maintenance of synapses and by 
participating in different forms of synaptic plasticity (Barres, 2008; Halassa et al., 
2007; Perea et al., 2009). Astrocytic processes are in close contact with synapses 
and can sense synaptic activity by detecting neurotransmitter release or by direct 
contact with pre- or postsynaptic membranes (Perea et al., 2009; Ventura and 
Harris, 1999). In this way astrocytes can monitor the activity of neuronal circuits 
and provide feedback signals to fine tune the properties of the network (figure 
1.4). On the other hand, changes in neuronal activity and synaptic strength can also 
affect glia physiology (Genoud et al., 2006; Pita-Almenar et al., 2006). The 
astrocytic processes together with the pre- and postsynaptic compartments 
constitute therefore a functional unit characterized by bidirectional communications 
between the single elements. Alterations of the physiological properties of glial 
cells have been involved in numerous pathologies that affect the CNS, including 
epilepsy and amyotrophic lateral sclerosis (ALS), a disease characterized by 
progressive loss of motor neurons (Seifert et al., 2006).   
 
1.4.1 The role of glia in synaptogenesis 
 
Factors released by glial cells are critical regulators of synaptogenesis. It 
was originally observed that the addition of glia to purified ganglion cells in 
cultures promotes the formation of synapses and strongly enhances pre- and 
postsynaptic function (Pfrieger and Barres, 1997; Ullian et al., 2001). Astrocytes 
release large matrix-associated proteins called thrombospondins that are sufficient 
to induce the formation of synapses with normal pre- and postsynaptic 
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ultrastructures. These synapses, however, lack AMPAR mediated currents. Astrocytes 
secrete an additional and still unknown factor that promotes full synaptic 
maturation (Christopherson et al., 2005). The secretion of thrombospondins by 
astrocytes may be controlled by neuronal activity (Barres, 2008). Thrombospondin 
expression in the CNS has greatly increased during evolution from primates to 
humans suggesting a contribution of glia to the enhanced complexity of the human 
brain (Caceres et al., 2007). 
 
1.4.2 Gliotransmission and its effect on synaptic function 
 
Atrocytes can sense synaptic activity through glutamate receptors present on 
their plasma membrane and respond by releasing neuroactive molecules 
(gliotransmitters), such as glutamate, D-serine, GABA and ATP, which bind to 
receptors localized in neuronal pre- and postsynaptic compartments (Perea et al., 
2009; Volterra and Meldolesi, 2005). Gliotransmission can be triggered by 
calcium transients in astrocytes induced by synaptic activity (Perea et al., 2009; 
Volterra and Meldolesi, 2005). The mechanisms responsible for the release of 
gliotransmitters are still under debate. Vesicle exocytosis, release from secretory 
lysosomes and transport across the plasma membrane through channels and 
transporters have been proposed (Perea et al., 2009; Volterra and Meldolesi, 
2005).   
Glutamate was one of the first molecules recognized as a gliotransmitter. 
Binding of glutamate released by astrocytes to presynaptic NMDARs or group I 
mGluRs increases the frequency of excitatory postsynaptic currents (Fiacco and 
McCarthy, 2004; Jourdain et al., 2007). Astrocytic glutamate can also induce 
network synchronization by binding to NMDARs in postsynaptic neurons (Fellin et 
al., 2004). Temporally coincident release of glutamate from astrocytes and 
postsynaptic depolarization can induce long lasting changes in synaptic strength at 
the CA3-CA1 synapse (Perea and Araque, 2007).  
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D-serine is a coagonist for NMDARs produced and released by astrocytes 
(Mothet et al., 2000; Mothet et al., 2005). In the supraoptic nucleus of the 
hypothalamus astrocytes undergo drastic morphological changes in different 
physiological conditions (Oliet and Piet, 2004). In basal conditions astrocytic 
processes tightly enwrap the synapses between the neurons that control release of 
hormones oxytocin and vasopressin into the bloodstream. During physiological 
events that require high concentrations of these hormones the processes of 
astrocytes retract and the concentration of astrocyte-released D-serine decreases. 
As a consequence activation of NMDARs is reduced and the threshold for induction 
of LTP is increased (Panatier et al., 2006). This metaplastic mechanism allows the 
selective potentiation of synaptic connections that are highly active during the 
physiologically relevant event.  
Glia can modulate neuronal activity also by releasing larger molecules. For 
example, glial cells control homeostatic synaptic scaling by secreting the cytokine 
tumor necrosis factor  (TNF) (Beattie et al., 2002; Stellwagen and Malenka, 
2006). 
 
1.4.3 Glial glutamate transporters 
 
Glutamate transporters are membrane proteins that use the electrochemical 
gradient to transport glutamate from the extracellular space into the cell (Beart 
and O'Shea, 2007; Tzingounis and Wadiche, 2007). They are also known as 
excitatory amino acid transporters (EAATs). Different subtypes of glutamate 
transporters coded by different loci have specific and diverse expression patterns. 
EAAT1, also known as glutamate/aspartate transporter (GLAST), and EAAT2, also 
known as glutamate transporter 1 (GLT1), are predominantly expressed in glia. 
EAAT3, alternatively called excitatory amino acid carrier 1 (EAAC1), is expressed 
by neurons throughout the brain. EAAT4 and EAAT5 display more restricted 
expression, being localized only in cerebellar Purkinje cells and in retinal rod 
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photoreceptors and bipolar cells respectively. Glial specific transporters are 
responsible for most of the glutamate uptake at the CA3-CA1 synapse (Bergles 
and Jahr, 1998). The structural properties of glutamate transporters are not fully 
understood. Some evidences suggest that functional transporters are homotrimeric 
complexes (Tzingounis and Wadiche, 2007). Glutamate transport is coupled to the 
cotransport of three Na+ ions and one H+ ion, and the countertransport of one K+ 
ion (Tzingounis and Wadiche, 2007). 
Glutamate uptake by astrocytes is a relatively slow process and it cannot 
account by itself for regulation of fast synaptic transmission (Tzingounis and 
Wadiche, 2007; Wadiche et al., 1995). However, glutamate transporters can 
modulate fast synaptic currents by buffering extracellular glutamate on a 
submillisecond time scale through rapid binding of the neurotransmitter (Diamond 
and Jahr, 1997; Tzingounis and Wadiche, 2007). Acute inhibition of glutamate 
transporters in hippocampal slices causes only very subtle changes of the kinetics 
and amplitude of synaptic currents induced with low frequency stimulation 
(Diamond and Jahr, 1997; Sarantis et al., 1993; Tzingounis and Wadiche, 2007). 
However, glutamate transporters control activation of peri- and extrasynaptic 
glutamate receptors and postsynaptic responses during trains of high frequency 
stimulation (Arnth-Jensen et al., 2002; Mulholland et al., 2008; Wadiche and Jahr, 
2005) with consequences also on synaptic plasticity. For example, neuronal EAAT4 
in Purkinje cells modulates LTD by controlling activation of perisynaptic mGluRs 
(Brasnjo and Otis, 2001; Wadiche and Jahr, 2005). In the hippocampus astrocyte 
glutamate transporters regulate mGluR-mediated excitation of interneurons (Huang 
et al., 2004). In the supraoptic nucleus of the hypothalamus changes of synaptic 
wrapping by astrocytes modify the amount of glutamate uptake and consequently 
alter synaptic transmission (Oliet et al., 2001). The impact of astrocytic glutamate 
uptake on synaptic plasticity at the CA3-CA1 synapse is not known. 
The presence of glial glutamate transporters is essential for the proper 
functionality of glutamatergic synapses and dysfunction of glutamate transport 
results in excitotoxicity and may be involved in pathological conditions, such as 
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epilepsy and ALS (Beart and O'Shea, 2007; Seifert et al., 2006). For example, 
genetic elimination of GLT1 and GLAST in mice causes neuronal cell death and 
increases susceptibility to seizures (Tanaka et al., 1997; Watase et al., 1998). 
 
1.4.4 Impact of synaptic changes on glia physiology 
 
So far only the influence of astrocytes on neuronal functions has been 
discussed. However, the communication between neurons and glia is bidirectional 
and changes in neuronal activity can also modify glial physiology. For example, 
stimulation patterns capable of triggering LTP at the CA3-CA1 synapse 
simultaneously induce upregulation of glutamate transport in astrocytes by 
increasing the expression of GLT1 in a PKA dependent manner (Ge and Duan, 
2007; Pita-Almenar et al., 2006). Sensory experience in vivo can also impact on 
astrocytes (Genoud et al., 2006). Whisker stimulation in mice induces an increase of 
GLAST and GLT1 expression in the corresponding cortical columns of the barrel 
cortex. The same sensory stimulation also causes an increase in astrocytic 
envelopment of excitatory synapses on dendritic spines.     
 
1.5 Eph receptors and ephrin ligands 
 
Eph receptors (from erythropoietin-producing hepatocellular carcinoma cell, 
the cell line from which their cDNAs were first isolated) constitute the largest family 
of receptor tyrosine kinases (RTKs) (Egea and Klein, 2007; Kullander and Klein, 
2002; Pasquale, 2008). They are divided into two subclasses on the basis of 
sequence similarity and binding affinity for their ephrin (Eph receptor interacting 
protein) ligands (Gale et al., 1996; Kullander and Klein, 2002). A-type receptors 
(nine members in mammals, EphA1-EphA8 and EphA10) typically bind to ephrinA 
ligands, while B-type receptors (five members in mammals, EphB1-B4 and EphB6) 
bind to ephrinBs. Exceptions to this rule are EphA4 receptor, which binds both 
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groups of ephrins (Kullander and Klein, 2002; Qin et al., 2010), and EphB2 that 
can bind ephrinA5, in addition to ephrinB ligands (Himanen et al., 2004). Eph 
receptors and ephrins have been identified in a wide variety of animal phyla 
including Porifera, Arthropoda (including Drosophila melanogaster), Nematoda 
(Cenorhabditis elegans) and Chordata (including Xenopus laevis, Danio renio, Mus 
musculus and Homo sapiens) (Drescher, 2002). Invertebrates have a lower number 
of Eph receptors and ephrins compared 
to vertebrates. For example in D. 
melanogaster there is one Eph receptor 
(D-Eph) and one ephrin (D-ephrin), and 
C. elegans has one Eph (VAB-1) and four 
ephrins (EFN1-4) (Drescher, 2002). The 
genomic amplification of loci coding for 
Ephs and ephrins during evolution has 
probably mirrored the increased 
numbers and complexity of physiological 
roles of these proteins.  
The Eph receptor extracellular 
region contains a ligand binding 
globular domain, a cysteine-rich region 
and two fibronectin type III repeats 
(figure 1.5). The intracellular region is 
composed of a juxtamembrane region 
containing two conserved tyrosines, a 
protein tyrosine kinase domain, a sterile 
alpha-motif (SAM) and a PDZ-domain 
binding motif. 
EphrinB ligands are 
transmembrane proteins with an 
Figure 1.5 Eph receptors and ephrin 
ligands. Schematic representation of the 
structural organization of Eph receptors 
and ephrin ligands. 
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extracellular receptor binding domain and an intracellular region containing a 
PDZ-binding motif. EphrinAs, on the other hand, have only an extracellular globular 
domain tethered to the cell membrane by a glycosylphosphatidylinositol (GPI) 
anchor (figure 1.5). Ephrin ligands lack intrinsic enzymatic activity. 
Three peculiar characteristics make Eph and ephrins unique among other 
RTKs. First, unlike many other RTKs, they are activated by membrane bound ligands 
but not by soluble monomeric ligands (Davis et al., 1994). Second, while other RTKs 
are fully activated after dimerization, Eph receptors usually need to form high-
order clusters to induce robust downstream signal transduction (Stein et al., 1998). 
Third, since ephrins are membrane bound molecules, upon binding receptor and 
ligand can transduce signals bidirectionally into both the receptor-expressing cell 
(known as forward signaling) and the ligand-expressing cell (known as reverse 
signaling) (Egea and Klein, 2007; Kullander and Klein, 2002; Pasquale, 2008). 
 
1.5.1 Eph forward signaling mechanisms 
 
The first step for the activation of Eph receptors is the transphosphorylation 
of several tyrosines that are located in the intracellular region of other Eph 
receptors that are recruited into the cluster (Kalo and Pasquale, 1999). In 
particular, phosphorylation of the two tyrosine residues in the juxtamembrane 
region is a crucial event to convert the kinase domain into its fully active 
conformation (Binns et al., 2000; Kullander et al., 2001a). Once the receptor is 
activated, adaptor proteins bind to it and regulate signal transduction into the cell 
(Kullander and Klein, 2002; Pasquale, 2008). These adaptor proteins often lack 
intrinsic enzymatic activity but contain protein-interaction domains, such as Src-
homology-2 (SH2) and SH3 domains, that are important for formation of signaling 
protein complexes (Pawson and Scott, 1997). The best characterized signaling 
pathway downstream of Eph receptors is the one that leads to changes in the actin 
cytoskeleton (figure 1.6). Small Rho family GTPases, including Rho, Rac and Cdc42, 
are key players in this pathway. These proteins function as bistable switches, 
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cycling between an active GTP-bound form and an inactive GDP-bound form 
(Heasman and Ridley, 2008). The balance between the two forms is regulated by 
guanine nucleotide-exchange factors (GEFs), that activate Rho GTPases by 
promoting the release of GDP and the binding of GTP, and GTPase-activating 
proteins (GAPs), that inactivate Rho GTPases by increasing the intrinsic GTPase 
activity of Rho proteins (Rossman et al., 2005). Eph receptors regulate the activity 
of Rho family GTPases by 
acting on GEFs, like 
ephexin (Sahin et al., 
2005; Shamah et al., 
2001) and Vav (Cowan 
et al., 2005), and GAPs 
like 2-Chimaerin (Beg et 
al., 2007; Iwasato et al., 
2007; Shi et al., 2007; 
Wegmeyer et al., 2007). 
Activation of RhoA by Eph 
receptors induces local 
depolymerization of actin 
filaments. At the same 
time Eph receptors inhibit 
Rac and Cdc42 and 
consequently block actin 
polymerization. These two 
pathways act in parallel 
to generate local collapse 
of the cytoskeleton. Other 
important signaling hubs, 
such as the phosphatidyl-
Figure 1.6 Eph receptor forward signaling. Schematic 
representation of some of the signaling pathways triggered 
by activation of Eph receptors. The scheme in the center of 
the figure represents the cytoplasmic domain of an Eph 
receptor. Red oval, kinase domain; green circle, SAM 
domain. The yellow circles marked with P represent 
phosphorylated tyrosines. 
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inositol 3-kinase (PI3K), Src family kinases and MAPKs, regulate a vast variety of 
cellular processes, including mitogenesis and cell adhesion, downstream of Eph 
receptor forward signaling (figure 1.6) (Kullander and Klein, 2002; Pasquale, 
2008). 
In some physiological contexts Eph receptor function does not require 
forward signaling. In some cases the ectodomain of the receptor is sufficient to 
activate ephrin-mediated reverse signaling in neighboring cells (Grunwald et al., 
2004; Henkemeyer et al., 1996; Kullander et al., 2001b). In other situations the 
ectodomain of Eph receptors interacts in cis with other membrane proteins, 
promoting their clustering in localized cellular compartments and modulating their 
function (Dalva et al., 2000; Takasu et al., 2002). 
  
1.5.2 Ephrin reverse signaling mechanisms 
 
While EphA and EphB receptors share very similar downstream pathways, 
the molecular signaling mechanisms downstream ephrinA and ephrinB ligands are 
mostly divergent due to the structural differences between the two families of 
proteins (Egea and Klein, 2007).  
 
1.5.2.1 EphrinB reverse signaling 
 
The mechanisms involved in ephrinB reverse signaling that have been 
described so far invariably depend on the protein cytoplasmic domain (figure 1.7) 
(Cowan and Henkemeyer, 2002; Egea and Klein, 2007; Kullander and Klein, 
2002). The signal transduction cascade is triggered by clustering of ephrinBs after 
binding to Eph receptors on adjacent cells. This event induces the recruitment and 
activation of Src family kinases that phosphorylate specific tyrosine residues of the 
ephrinB intracellular region (Palmer et al., 2002). The phospho-tyrosines function as 
docking sites for proteins with SH2 domains, such as Grb4, that in turn activate 
downstream signaling pathways regulating different physiological processes, 
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including remodeling of the actin cytoskeleton and cell adhesion (Cowan and 
Henkemeyer, 2001; Segura et al., 2007; Xu and Henkemeyer, 2009). EphrinBs can 
also activate downstream molecular targets independently from phosphorylation of 
the tyrosine residues by interactions of the PDZ-binding motif with PDZ domain-
containing proteins. These proteins can be adaptors without intrinsic enzymatic 
activity like GRIPs and syntenin (Bruckner et al., 1999; Grootjans et al., 2000), or 
proteins containing functional units, such as PDZ-RGS3 (Lu et al., 2001). These 
interactions can be relevant for clustering and stabilizing other membrane proteins 
on the cell surface (Essmann et al., 2008) or can modulate signaling cascades 
downstream of other receptors (Lu et al., 2001). For example activation of 
ephrinB1 inhibits G-protein-coupled receptor CXCR4 signaling through recruitment 
of PDZ-RGS3. This protein contains a regulator of heterotrimeric G-protein-coupled 
receptor (RGS3) domain that acts as a GAP for the  subunit of trimeric G 
proteins, catalyzing the hydrolysis of GTP to GDP and therefore inactivating the 
molecular cascade downstream of CXCR4 (Lu et al., 2001). 
Figure 1.7 EphrinB reverse signaling. 
Schematic representation of some of the 
pathways downstream of ephrinBs. Src 
phosphorylates specific tyrosines in the 
cytoplasmic domain of ephrinBs allowing the 
docking of adaptor proteins, such as Grb4. 
Interactions of these adaptors with specific 
enzymes trigger biochemical changes 
downstream of ephrinBs. Signaling 
molecules, such as PDZ-RGS3, interact with 
the PDZ-binding motif at the C-terminus of 
ephrinBs and modulate intracellular 
signaling pathways. 
___________________________________ 
                                                                              1 Introduction 
 
 
31 
 
1.5.2.2 EphrinA reverse signaling  
 
EphrinA reverse signaling has been implicated in a wide variety of 
physiological processes including axon guidance (Knoll et al., 2001; Lim et al., 
2008b; Marquardt et al., 2005), cell migration (Coate et al., 2009), neurogenesis 
(Holmberg et al., 2005), insulin secretion (Konstantinova et al., 2007) and cell 
adhesion (Davy et al., 1999; Davy and Robbins, 2000; Huai and Drescher, 2001). 
However, the molecular mechanisms mediating ephrinA reverse signaling are 
poorly understood. Since ephrinA ligands lack a cytoplasmic domain, the 
mechanisms of signal transduction are radically different from ephrinB signaling. 
EphrinAs can use two different strategies for activating downstream molecular 
pathways (figure 1.8). First, they can interact in cis with a coreceptor (Lim et al., 
2008b; Marler et al., 2008), similarly to other GPI-membrane bound proteins, such 
as the glial cell line-derived neurotrophic factor (GDNF) receptors (Airaksinen and 
Saarma, 2002). In this case ephrinA clustering modulates the intrinsic activity of 
associated transmembrane proteins. For example, in the axons of ganglion cells of 
the retina ephrinA repulsive effect during retinotopic map formation is mediated by 
the neurotrophin receptor p75 (Lim et al., 2008b). At later stages of development 
ephrinAs interact with TrkB in the axons of ganglion cells to control branching and 
synaptogenesis (Marler et al., 2008). The second mechanism used by ephrinA 
ligands to trigger reverse signaling may involve local modification of the 
membrane physical properties that causes the recruitment and activation of 
intracellular membrane-bound proteins. GPI-linked proteins, including ephrinAs, are 
often localized in specialized cell membrane microdomains rich in cholesterol and 
sphingolipids called lipid rafts (Brown and London, 1998; Tsui-Pierchala et al., 
2002). It has been proposed that clustering of GPI-anchored proteins induces the 
formation of larger raft domains, which allows the interaction with signaling 
molecules attached to the inner surface of the rafts (Brown and London, 1998). 
Such a mechanism has been suggested for the ephrinA dependent activation of Src 
family kinases (Davy et al., 1999). 
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1.5.3 Cis versus trans interactions 
 
Very often Eph receptors and ephrins are coexpressed in the same cells 
(Egea and Klein, 2007). The physiological implications of this observation are still 
controversial. It has been suggested that receptors and ligands can interact in cis. 
Such a scenario has been described for EphA3 and ephrinA5 in the growth cones of 
axons of retinal ganglion cells (Carvalho et al., 2006). In this case the interaction 
between receptor and ligand on the same cell membrane inhibits Eph forward 
signaling, probably by preventing the interaction between EphA3 and ephrinAs in 
trans. Other studies instead suggested that coexpressed receptors and ligands do 
not interact in cis. For example, it has been proposed that ephrinAs and EphAs in 
the growth cones of axons of spinal cord motor neurons segregate in distinct 
microdomains where they mediate opposing cellular responses, with ephrinAs 
Figure 1.8 Mechanisms of ephrinA reverse signaling. Scheme showing 
two different mechanisms proposed for ephrinA signaling transduction. 
Left: ephrinAs interact with transmembrane proteins (coreceptors), such as 
p75 and TrkB. Right: ephrinA clustering induces local plasma membrane 
changes that, in turn, trigger recruitment of Src family kinases. 
_____________________________________________________ 
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signaling attraction and EphAs inducing repulsion (Marquardt et al., 2005). 
Opposing functions and at least partial segregation of coexpressed Ephs and 
ephrins were also shown in pancreatic  cells, where EphA forward signaling 
inhibits, while ephrinA reverse signaling enhances insulin secretion (Konstantinova et 
al., 2007). 
 
1.5.4 The role of Eph receptors and ephrins in synaptic plasticity 
 
Eph receptors and ephrin ligands have been shown to be involved in a wide 
variety of processes during nervous system development including axon guidance, 
cell migration, proliferation and apoptosis (Kullander and Klein, 2002; Pasquale, 
2008). However, the function of Ephs and ephrins is not restricted to embryonic 
development. Indeed, most of the receptors and ligands are highly expressed in 
the adult nervous system (Grunwald et al., 2001; Liebl et al., 2003), where they 
regulate structural and functional synaptic plasticity (Klein, 2009). 
 
1.5.4.1 Modulation of structural plasticity by Ephs and ephrins 
 
Different Eph receptors and ephrins are involved in the regulation of spine 
morphogenesis. Modulation of spine shape can involve both forward and reverse 
signaling (Klein, 2009). It has been shown that molecular events downstream of 
multiple EphB receptors and EphA4 are required for proper maturation of dendritic 
spines (Carmona et al., 2009; Henkemeyer et al., 2003; Murai et al., 2003). 
Neurons lacking EphB1-3 display loss and defective maturation of spines in vitro 
and in vivo. However, neurons lacking only one of the receptors have normal spines 
suggesting that EphBs are functionally redundant (Henkemeyer et al., 2003). EphB 
receptors clustering initiate parallel molecular pathways that lead to the 
remodeling of the actin cytoskeleton in spines (figure 1.9). For example the Rho-
GEF Kalrinin is recruited into the EphB clusters and induces the Rac1 mediated 
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activation of p21-activated kinases (PAKs), which ultimately trigger actin 
depolymerization (Penzes et al., 2003). This pathway is influenced by NMDAR 
activity. EphB receptors activation by ephrinBs induces the phosphorylation and 
recruitment of the Rac1-GEF Tiam1 to EphB complexes that also contain NMDARs 
(Tolias et al., 2005; Tolias et al., 2007). Tiam1 is phosphorylated in a calcium-
dependent manner in response to NMDAR activity (Tolias et al., 2005). Another 
way for EphBs to influence spine morphology is to recruit the multi-domain scaffold 
protein Intersectin that controls local formation and branching of actin filaments by 
regulating the activaty of Cdc42 (Irie and Yamaguchi, 2002). 
Stimulation of EphA4 forward signaling in hippocampal slice cultures by 
application of preclustered ephrinA3 decreases spine length and density (Murai et 
al., 2003). On the contrary, Epha4 and Efna3 null mutant mice display spine 
elongation and shape distortions in vivo, although the phenotype is much milder 
than in vitro (Carmona et al., 2009; Murai et al., 2003). Since EphA4 is enriched in 
dendritic spines and ephrinA3 is mainly localized in astrocytes in the adult mouse 
hippocampus, EphA4-ephrinA3 mediated neuroglia interaction has been proposed 
to regulate dendritic spine shape. Similarly to EphB receptors, EphA4 controls spine 
Figure 1.9 Molecular pathways 
regulating spine morphogenesis 
downstream of EphB receptors. EphBs 
regulate actin dynamics by activating 
small GTPases, such as Rac1 and Cdc42, 
through GEFs, including Kalrinin and 
Tiam1 or by recruiting multidomain 
scaffold proteins, such as Intersectin. 
Some of the pathways are influenced by 
synaptic activity. For example the GEF 
Tiam1 requires calcium entry through 
NMDARs to be activated. 
_____________________________ 
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morphology by affecting the dynamics of actin cytoskeleton (figure 1.10). EphA4 
clustering induces the recruitment and activation of cyclin-dependent kinase 5 
(Cdk5) that phoshorylates the Rho-GEF ephexin1, causing the RhoA-mediated 
rearrangement of actin filaments (Fu et al., 2007). In addition, binding of ephrinA3 
to EphA4 induces the activation of the actin depolymerizing/severing factor cofilin 
mediated by phospholipase C1 (PLC1) (Zhou et al., 2007). Modulation of spine 
morphology by EphA4 involves also inhibition of 1-integrin-dependent adhesion. 
Activation of EphA4 by ephrinA3 triggers the disassembling of integrin signaling 
complexes containing the Crk-associated substrate (Cas) the focal adhesion kinase 
(FAK) and the proline-rich tyrosine kinase 2 (Pyk2) (Bourgin et al., 2007). An 
additional mechanism used by EphA4 to modulate integrin function involves the 
recruitment, through its PDZ interacting motif, of the spine-associated RapGAP that 
inactivates Rap1 and consequently inhibits integrin-mediated adhesion (Richter et 
al., 2007). 
Also ephrinB 
reverse signaling has 
been implicated in 
modulation of structural 
plasticity. Clustering of 
ephrinBs promotes the 
maturation of spines in 
vitro through a 
signaling pathway 
involving Grb4, G 
protein-coupled 
receptor kinase 
interacting protein 1 
(GIT1) and the Rac-GEF 
-PIX (Segura et al., 
 
 
 
Figure 1.10 Regulation of spine morphogenesis by 
EphA4-ephrinA3 interaction at the neuro-glia interface. 
Binding of astrocytic ephrinA3 to EphA4 on dendritic spines 
triggers parallel pathways that lead to actin cytoskeleton 
remodeling and inhibition of integrin-mediated cell 
adhesion. 
___________________________________________ 
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2007; Zhang et al., 2005). 
 
1.5.4.2 Modulation of functional plasticity by Ephs and ephrins 
 
Eph receptors and ephrins not only control spine morphogenesis but also 
modulate functional synaptic plasticity (figure 1.11) (Klein, 2009). It has been 
shown that EphB2 directly interacts with NMDARs (Dalva et al., 2000; Grunwald et 
al., 2001) and modulates their function (Takasu et al., 2002). Activation of EphB2 
induces phosphorylation of NMDARs by Src family kinases thereby potentiating 
NMDAR-dependent influx of calcium (Takasu et al., 2002). These events result in 
enhanced NMDAR-dependent gene expression and require EphB2 kinase activity. 
Ephb2 null mutant mice have impaired LTP and LTD at the CA3-CA1 synapse and 
impaired LTP at the perforant path-dentate granule synapse (Grunwald et al., 
2001; Henderson et al., 2001). Moreover, they display reduced NMDAR synaptic 
currents and NMDAR density in postsynaptic compartments (Henderson et al., 
2001). However, EphB2 kinase activity is dispensable for long term synaptic 
plasticity modulation, suggesting that EphB2-dependent clustering of NMDARs may 
be sufficient to regulate their function. Alternatively, EphB2 could be required in the 
presynaptic bouton to activate postsynaptic ephrinB reverse signaling.  
Similarly to EphB2, EphA4 modulates LTP and LTD at the CA3-CA1 synapse 
in a kinase-independent fashion (Grunwald et al., 2004). However, differently 
from EphB2, EphA4 does not interact with NMDARs (Dalva et al., 2000) and the 
molecular mechanisms involved in its function have been elusive. EphA4 is localized 
in both presynaptic bouton and postsynaptic spine (Tremblay et al., 2007) and it 
could be required in both or only one of the two compartments.  
Also ephrinB reverse signaling modulates functional synaptic plasticity. 
EphrinB2 and ephrinB3 are enriched in CA1 region and dentate gyrus of the 
hippocampus (Grunwald et al., 2004; Grunwald et al., 2001). Efnb2 conditional 
knockouts and Efnb3 null mutant mice have impaired LTP and LTD at the CA3-CA1 
synapse (Grunwald et al., 2004). Tyrosine phosphorylation sites in the ephrinB2 
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cytoplasmic domain are necessary to promote LTP but not LTD, while the ephrinB2 
PDZ binding motif is required for both forms of plasticity (Bouzioukh et al., 2007). It 
has been suggested that one mechanism used by ephrinB2 to control synaptic 
plasticity may involve stabilization of AMPARs at the synapse through a mechanism 
mediated by GRIPs (Essmann et al., 2008). EphrinB3 reverse signaling appears to 
be dispensable for regulation of synaptic plasticity at the CA3-CA1 synapse but is 
required at the mossy fiber-CA3 synapse (Armstrong et al., 2006). At this synapse 
tetanic stimulation of mossy fibers induces clustering of postsynaptic EphB2 through 
a mechanism requiring GRIPs (Contractor et al., 2002). Clustering of postsynaptic 
EphB2 triggers ephrinB reverse signaling in the presynaptic compartment that, in 
turn,  promotes   LTP   possibly  by  activating  PKA  signaling   and  ultimately   by  
 
Figure 1.11 Eph receptors and ephrins 
promote LTP and LTD at the CA3-CA1 
synapse. The EphB2 receptor interacts with 
NMDARs and regulates their clustering and 
activity. Acivation of EphB2 forward signaling, 
most likely by presynaptic ephrinBs, induces 
phosphorylation of NMDARs by Src, regulating 
in this way their calcium permeability. 
However, EphB2 promotes LTP and LTD in a 
kinase-independent fashion. EphA4 modulates 
LTP and LTD in a forward signaling-
independent fashion. EphA4 could be required 
in the presynaptic bouton to activate 
postsynaptic ephrinB reverse signaling or could 
act in the dendritic spine through an unknown 
mechanism. EphrinB2, but not ephrinB3, reverse signaling promotes long term synaptic plasticity at 
the CA3-CA1 synapse. It is not clear yet if ephrinBs are required in the pre- or postsynaptic 
compartment. 
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increasing glutamate release from mossy fiber boutons. EphrinB reverse signaling 
has also been involved in the modulation of synaptic function in the retinotectal 
circuit of Xenopus laevis tadpoles (Lim et al., 2008a). Here, activation of ephrinB1 
reverse signaling in axon terminals induces rapid increase of transmitter release 
and delayed enhancement of postsynaptic currents. 
While the mechanisms underlying the functions of Eph receptors and ephrin 
ligands in structural plasticity are well characterized, the details of their roles in 
functional plasticity are still elusive. 
 
1.6 Summary of the thesis project 
 
As outlined in the introduction it was already known that EphA4 is involved in 
LTP modulation at the CA3-CA1 synapse (Grunwald et al., 2004). However, the 
molecular mechanism underlying EphA4 function in LTP regulation was not 
understood. It was suggested that EphA4 in the presynaptic bouton could modulate 
LTP by activating ephrinB reverse signaling in the postsynaptic compartment (figure 
1.11) (Grunwald et al., 2004). This conclusion was based on three evidences: i) 
EphA4 forward signaling is dispensable for this function; ii) the ephrinB2 and 
ephrinB3 ligands also promote LTP at the CA3-CA1 synapse; iii) the two ligands 
are mostly localized in the postsynaptic side at the CA3-CA1 synapse. However, 
this model could not be rigorously proven because EphA4 is expressed in both CA3 
and CA1 pyramidal neurons. For this reason I analyzed mice with conditional Epha4 
alleles in combination with CA1- and CA3-specific Cre lines. Contrary to the initial 
working model, I found that postsynaptic EphA4 is important for modulating LTP, 
while EphA4 localized in the presynaptic axon is dispensable.  
It was known that dendritic EphA4 can bind ephrinA3 present in astrocytes 
(Murai et al., 2003). This idea was further strengthened by a recent study showing 
that EphA4 is mostly localized in the perisynaptic region of dendritic spines and 
presynaptic boutons where it cannot be engaged in a transsynaptic interaction but 
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could easily interact with astrocytic membrane proteins (Tremblay et al., 2007). 
These evidences led me to hypothesize that the interaction between dendritic 
EphA4 and glial ephrinA3 could be important for LTP modulation.  In agreement 
with this hypothesis I found that Efna3 null mutant mice have impaired LTP. Further 
work showed that EphA4-ephrinA3 interaction at the neuro-glia interphase 
modulates LTP by controlling the amount of glial glutamate transporters present in 
astrocytes and as a consequence the concentration of glutamate near synapses. 
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2.1 Characterization of a novel Epha4 conditional allele 
 
To investigate the function of EphA4 in the pre- or postsynaptic compartment 
at the CA3-CA1 synapse a new conditional allele of Epha4 (hereafter referred to 
as Epha4lx) was used (Filosa et al., 2009; Klas Kullander, unpublished results). 
Western blot analysis of hippocampal protein extracts revealed that EphA4 
expression in Epha4lx/lx mice was reduced to 15-20% when compared to Epha4+/+ 
mice (figure 2.1a). However, this reduction did not cause phenotypic alterations, 
such as anterior commisure and dorsal funiculus defects and synchronous hindlimb 
locomotion that were previously described in Epha4 null mutants (Kullander et al., 
2001b) (figure 2.1b,d,f). These phenotypes were instead evident when EphA4 was 
ubiquitously removed in PGK-cre;Epha4lx/lx mice (Lallemand et al., 1998) (figure 
2.1c,e,g). 
These results demonstrated that the Epha4lx allele, although hypomorphic, 
does not cause any major phenotypes present in Epha4 null mice and that it can be 
efficiently recombined in presence of Cre. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                     2 Results 
 
 
42 
 
Figure 2.1 (previous page) Validation of the Epha4lx allele. (a) EphA4 protein level analysis by 
western blot in P40 hippocampal protein extracts from two Epha4+/+ and two Epha4lx/lx mice (left 
blot) and from Epha4+/+, PGK‐ cre;Epha4lx/lx and Epha4–/– mice (right blot); tubulin was used as 
loading control. (b,c) Bright-field microscopy images of horizontal adult brain sections showing 
normal anterior commissure (AC, arrowheads) in Epha4lx/lx mice (b) but not in PGK‐ cre;Epha4lxlx 
mutants (c). (d,e) Dark‐field images of cross sections of adult lumbar spinal cord. The ventral part 
of the dorsal funiculus containing corticospinal tract axons was normal in Epha4lx/lx mice (d), but 
greatly reduced in PGK‐ cre;Epha4lx/lx mutants (e) as revealed by the increased distance (black 
square bracket) between the dorsal funiculus to the central canal (*). Scale bars: 500 μm. (f,g) 
Gait analysis; to evaluate placement of paws during walking forepaws and hindpaws were 
coated in blue and red ink, respectively. Epha4lx/lx mice show normal gait with alternative steps (f), 
whereas PGK‐cre;Epha4lx/lx mice show a hopping gait characteristic of Epha4–/– mice (g). Data 
generated by S. Paixao. 
___________________________________________________________________________ 
 
2.2 Hippocampal long term synaptic plasticity is not altered in 
Epha4lx/– mice  
 
Because of the reduced expression of EphA4, the hypomorphic Epha4lx 
allele may cause alterations of hippocampal long term synaptic plasticity that have 
been previously shown in Epha4 null mutants (Grunwald et al., 2004). To test this 
possibility I analyzed LTP at the CA3-CA1 synapse in acute hippocampal slices 
obtained from Epha4lx/– and Epha4lx/+ mice. Extracellular recordings did not reveal 
LTP defects in Epha4lx/– mice, which had only one intact Epha4 allele, compared to 
Epha4lx/+ mice up to 1 h after application of TBS or one tetanus to Schaffer 
collaterals (figure 2.2).  
These results indicated that Epha4lx/– mice could be used as controls in 
experiments investigating the role of EphA4 in LTP at the CA3-CA1 synapse. 
Epha4lx/– and not Epha4lx/lx mice were used as controls in the experiments described 
in this thesis to avoid variability of EphA4 expression due to potential Cre-
mediated germ line recombination. 
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Figure 2.2 Normal LTP in Epha4lx/– mice. (a,b) Graphs displaying LTP, represented as percentage 
of the baseline, induced with three TBSs (a) or one tetanus (b). Insets: representative traces from 
controls (black traces) and mutants (gray traces) recorded before (stars) and 55‐60 min after 
(triangles) LTP induction. The stimulation artifacts were removed. Epha4lx/+ and Epha4lx/– mice had 
similar amount of potentiation at 55‐60 min after LTP induction (TBS: 142.1 ± 11.8 % in Epha4lx/+, 
n = 8 slices, 5 mice, versus 145.4 ± 10.3 % in Epha4lx/–, n = 8 slices, 5 mice, t‐test, P = 0.8; 
tetanus: 140.2 ± 5.7 % in Epha4lx/+, n = 10 slices, 8 mice, versus 141.5 ± 8.9% in Epha4lx/–, n = 
10 slices, 8 mice, t‐test, P = 0.9). Error bars, s.e.m. 
___________________________________________________________________________ 
 
2.3 Efficient subregion-specific elimination of EphA4 in adult 
hippocampus 
 
To generate CA1 pyramidal cell-specific Epha4 knockout mice, I used the 
R4Ag11CamKII-cre mouse line (hereafter referred to as CA1-cre) which recombines 
in CA1 cells starting from the second postnatal week (Tsien et al., 1996). To 
generate CA3 pyramidal cell-specific Epha4 knockout mice, I used a new knock-in 
mouse line, which expresses Cre from the endogenous Grik4 locus (hereafter 
referred to as CA3-cre) starting from the first postnatal week (Filosa et al., 2009). 
CA1-cre;Epha4lx/– and CA3-cre;Epha4lx/– mice were viable and fertile, and 
exhibited no gross developmental abnormalities. The recombination efficiencies in 
the CA1-cre;Epha4lx/– and CA3-cre;Epha4lx/– lines were quantified by densitometric 
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analysis of Epha4 mRNA in situ hybridizations and calculated to be approximately 
80% for both lines (figure 2.3). 
These results demonstrated that efficient sub-region specific elimination of 
EphA4 in the hippocampus could be achieved by combining the Epha4lx allele with 
the CA1-cre and CA3-cre lines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Efficient sub-region-specific recombination of Epha4 floxed allele in the hippocampus. 
(a) In situ hybridization showing Epha4 mRNA expression in the dentate gyrus (DG), CA3 and CA1 
regions of the hippocampus of an adult EphA4lx/– mouse. The small squares indicate the regions 
used for densitometric measurements for calculating the recombination efficiency (details in the 
materials and methods section). (b,c) In situ hybridizations for Epha4 showing highly reduced 
expression of the mRNA in CA1 in CA1-cre; Epha4lx/– mice (b) and in CA3 in CA3-cre; Epha4lx/– 
mice (c). (d,e) Bar graphs depicting the CA1/CA3 ratio (in percentage) of Epha4 mRNA 
hybridization signal strength in Epha4lx/– (d, black bar) and CA1-cre; Epha4lx/– (d, white bar) mice 
or the CA3/CA1 ratio (in percentage) in Epha4lx/– (e, black bar) and CA3-cre;Epha4lx/– (e, white 
bar) mice (CA1/CA3 ratio: 20% ± 12% in CA1-cre;Epha4lx/– mice, compared to 91% ± 4% in 
Epha4lx/– controls; CA3/CA1 ratio: 24% ± 4% in CA3-cre;Epha4lx/– animals, compared to 116% 
± 7% in Epha4lx/– controls; n = 3-5 mice; t-test, *** P < 0.0001). Scale bars, 500 m. Error bars, 
s.e.m. 
__________________________________________________________________________ 
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2.4 Normal basal synaptic transmission in Epha4 mutants 
 
Before analyzing LTP, I performed a careful analysis of potential alterations 
of basal synaptic transmission in CA1-cre;Epha4lx/– and CA3-cre;Epha4lx/– mice. 
Extracellular recordings of the CA3-CA1 pathway in acute hippocampal slices from 
CA1-cre;Epha4lx/–, CA3-cre;Epha4lx/– and control mice revealed similar amplitudes 
of the presynaptic fiber volley (FV), which is proportional to the number of axons 
recruited by electrical stimulation (figure 2.4a,b). Also the slopes of field excitatory 
postsynaptic potentials (fEPSPs) at various stimulation intensities were not altered in 
Epha4 mutants, indicating normal postsynaptic responses to presynaptic stimulation 
(figure 2.4a,b). These data revealed linear relations between synaptic inputs (FVs) 
and postsynaptic responses (fEPSPs) in CA1-cre;Epha4lx/– and CA3-cre;Epha4lx/– 
mice that were comparable to the ones obtained from control mice. 
Furthermore, PPF at various interstimulus intervals (ISIs) was normal in mutant 
mice, indicating that the probability of synaptic vesicle release was comparable in 
mutant and control mice (figure 2.5a,b). Fiber volley amplitudes, fEPSP slopes and 
PPF were normal also in Camk2a-cre;Epha4lx/– mice, in which EphA4 was removed 
from forebrain neurons, including pyramidal cells in CA3 and CA1 regions of the 
hippocampus, starting from the second postnatal week (Minichiello et al., 1999) 
(figure 2.4c, 2.5c). 
Moreover, whole-cell voltage-clamp analysis showed no alterations in 
AMPAR/NMDAR current ratio in CA1 pyramidal cells of acute hippocampal slices 
obtained from Epha4 null mutants (figure 2.6), revealing normal function of 
postsynaptic ionotropic glutamate receptors in basal conditions. 
Taken together, these data showed that hippocampal basal synaptic 
transmission is not perturbed in Epha4 mutants. 
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Figure 2.4 Normal axonal function and postsynaptic responses in Epha4 mutants. (a,b,c) Left: 
relations between presynaptic fiber volley (FV) amplitudes and fEPSP slopes at various stimulus 
intensities. Right: representative traces of fEPSPs at various stimulation intensities in controls (black 
traces) and mutants (gray traces). The stimulation artifacts were removed. (a) Normal fEPSPs in 
CA1‐cre;Epha4lx/– mice (Epha4lx/–, n = 16 slices, 5 mice, per group, CA1‐cre;Epha4lx/–, n = 16 
slices, 5 mice, per group, ANCOVA, P = 0.1). (b) In the FV range of 0.1‐0.3 mV Epha4lx/– controls 
(n = 17 slices, 6 mice per group) and CA3‐cre;Epha4lx/– mutants (n = 17 slices, 6 mice per group) 
showed similar values (ANCOVA, P = 0.07). (c) Camk2a‐cre;Epha4lx/– mutants had normal fEPSP 
slopes at various stimulus intensities compared to Epha4lx/– controls (n = 11 slices, 4 mice per 
group, ANCOVA, P = 0.2). Error bars, s.e.m. 
_________________________________________________________________________ 
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Figure 2.5 Normal PPF in Epha4 mutants. (a,b,c) Left: PPF of the fEPSPs, at various interstimulus 
intervals (ISIs) from (a) CA1‐cre;Epha4lx/– and Epha4lx/– mice (n = 14 slices, 5 mice per group, 
two‐way repeated measures ANOVA, between genotypes: F1,130 = 0.09, P = 0.8), from (b) 
CA3‐cre;Epha4lx/– and Epha4lx/– mice (n = 13 slices, 4 mice per group, two‐way repeated 
measures ANOVA, between genotypes: F1,120 = 0.2, P = 0.9) and from (c) Camk2a‐cre;Epha4lx/– 
and Epha4lx/– mice (n = 14 slices, 7 mice per group, between genotypes: F1,130 = 0.4, two‐way 
repeated measures ANOVA, P = 0.6). Right: representative traces showing PPF at 40 ms ISI in 
controls (black traces) and mutants (gray traces). The stimulation artifacts were removed. Error 
bars, s.e.m. 
____________________________________________________________________________ 
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Figure 2.6 Normal AMPAR- and NMDAR-mediated 
currents in Epha4–/– mice. Histogram showing the ratios 
between AMPAR and NMDAR currents (I) in Epha4+/+ and 
Epha4–/– mice (Epha4+/+: 4.5 ± 0.8; Epha4–/–: 3.3 ± 0.8, n 
= 6 cells, 6 mice per group, P = 0.3, t‐test). Inset: 
representative average evoked currents recorded at –70 
mV (lower traces) or +40 mV (upper traces) (Epha4+/+: 
black traces; Epha4–/–: gray traces). The stimulation 
artifacts were removed. Error bars, s.e.m. 
______________________________________________ 
 
 
2.5 EphA4 is required for LTP in postsynaptic CA1 cells  
 
To investigate a requirement for either postsynaptic or presynaptic EphA4 
for LTP modulation at the CA3-CA1 synapse, I induced LTP with TBS in acute 
hippocampal slices from Epha4 mutant and control mice. After recording a stable 
baseline, three TBS were given to fibers of the CA3 presynaptic neurons, and 
postsynaptic responses were recorded from stratum radiatum of CA1 region with an 
extracellular electrode for up to 60 min post stimulation. CA1-cre;Epha4lx/– mice 
had a marked reduction in LTP compared to littermate Epha4lx/– controls (figure 
2.7a). A similar LTP reduction was observed also in Camk2a-cre;Epha4lx/– mice 
(figure 2.7b). In contrast, TBS-induced LTP was not altered in CA3-cre;Epha4lx/– 
mice (figure 2.7c). 
These results demonstrated that EphA4 functions postsynaptically to regulate 
LTP at the CA3-CA1 synapse. 
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Figure 2.7 EphA4 is required for TBS-induced 
LTP in postsynaptic CA1 cells. (a-c) Scatter 
plots showing LTP, represented as  percentage 
of the baseline, induced by stimulation of 
Schaffer collaterals with three TBSs. Insets: 
representative traces from controls (black) and 
mutants (gray) recorded before (stars) and 
55-60 min after (triangles) LTP induction. The 
stimulation artifacts were removed. (a) CA1-
cre;Epha4lx/– mice showed a marked deficit in 
TBS-induced LTP compared to littermate 
Epha4lx/– controls (123.0 ± 4.4% in mutants, n 
= 12 slices, 7 mice; versus 144.8 ± 7.6% in 
controls, n = 14 slices, 7 mice; at 55-60 min 
after induction, t-test, P = 0.02). (b) 
Camk2a‐cre;Epha4lx/– mice had impaired TBS-
induced LTP (123.4 ± 4.8% in mutants, n = 12 
slices, 10 mice, versus 149.0 ± 6.1% in 
controls, n = 13 slices, 10 mice, at 55‐60 min 
after induction, t‐test, P = 0.003). (c) CA3-
cre;Epha4lx/– mice showed normal TBS-induced 
LTP (142.9 ± 10.0% in mutants, n = 10 slices, 
8 mice; versus 136.9 ± 9.7% in controls, n = 
10 slices, 8 mice; at 55–60 min after 
induction, t-test, P = 0.7). Error bars, s.e.m. 
____________________________________ 
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2.6 Tetanus-induced LTP does not require EphA4 
 
LTP can be induced at the CA3-CA1 synapse with different patterns of high 
frequency stimulation (Albensi et al., 2007). Differences in induction protocols can 
result in diverse outcomes when LTP is analyzed in presence of pharmacological or 
genetic  manipulations  (Shalin et al.,  2006;  Zakharenko et al.,  2003).  To better  
 
Figure 2.8 EphA4 is dispensable for tetanus-
induced LTP. (a-c) Graphs showing LTP, 
represented as percentage of the baseline, 
induced by stimulation of Schaffer collaterals with 
one tetanus. Insets: representative traces from 
controls (black) and mutants (gray) recorded 
before (stars) and 55-60 min after (triangles) LTP 
induction. The stimulation artifacts were removed.  
CA1-cre;Epha4lx/– (a), Camk2a‐cre;Epha4lx/– (b) 
and CA3-cre;Epha4lx/– (c) mice had normal 
tetanus-induced LTP (CA1-cre;Epha4lx/–  mice: 
142.8 ± 6.0% in mutants, n = 11 slices, 9 mice; 
versus 151.0 ± 11.0% in controls, n = 12 slices, 9 
mice; at 55-60 min after induction, t-test, P = 0.5; 
Camk2a‐cre;Epha4lx/–: 148.0 ± 9.0% in mutants, n 
= 13 slices, 9 mice, versus 138.6 ± 5.2% in 
controls, n = 15 slices, 9 mice, at 55‐60 min after 
induction, t‐test, P = 0.4; CA3-cre;Epha4lx/– mice: 
133.8 ± 7.9% in mutants, n = 10 slices, 8 mice; 
versus 134.0 ± 5.4% in controls, n = 9 slices, 8 
mice; at 55–60 min after induction, t-test, P = 
1.0). Error bars, s.e.m. 
________________________________________ 
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characterize the role of EphA4 in long term synaptic plasticity modulation I 
analyzed LTP induced with one tetanus in Epha4 mutants. Surprisingly, CA1-
cre;Epha4lx/– and Camk2a-cre;Epha4lx/– mice did not display any LTP defects under 
these conditions (figure 2.8a,b). Similar results were obtained with CA3-
cre;Epha4lx/– mice (figure 2.8c). 
These data indicated that EphA4 is dispensable for tetanus-induced LTP. 
Therefore, EphA4 is differentially engaged in LTP modulation depending on the 
stimulation pattern used for LTP induction. 
 
2.7 EphrinA3 is required for TBS-induced LTP 
 
The fraction of EphA4 that is localized in dendrites has previously been 
shown to respond to ephrinA3 present in hippocampal astrocytes (Carmona et al., 
2009; Murai et al., 2003). Consistent with such a model, immune electron 
microscopic studies have suggested that EphA4 is localized mainly perisynaptically 
(Tremblay et al., 2007) where it could easily interact with proteins on the surface 
of astrocytic processes rather than with presynaptic binding partners. Therefore 
EphA4 may modulate LTP by interacting with astrocytic ephrinA3, possibly inducing 
some biochemical change in astrocytes. Therefore, I examined LTP at the CA3-CA1 
synapse in Efna3 null mutant mice (Carmona et al., 2009). Application of three TBS 
to Schaffer collaterals in acute hippocampal slices from Efna3–/– mice revealed a 
strong inhibition of LTP compared to Efna3+/+ controls (figure 2.9a). Interestingly, 
like EphA4 mutants, Efna3–/– mice displayed reduced TBS-induced LTP but normal 
tetanus-induced LTP (figure 2.9b). 
These findings suggested that EphA4 interacts with ephrinA3 to mediate 
TBS-induced LTP at the CA3-CA1 synapse. 
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Figure 2.9 Impaired TBS-induced LTP in Efna3 null mutants. (a,b) Scatter plots showing LTP induced 
by stimulation of presynaptic CA3 neurons with three TBSs (a) or a single tetanus (b). (a) Efna3–/– 
mice showed a strong deficit in TBS-induced LTP compared to Efna3+/+ controls (Efna3+/+, 140.7 ± 
6.1%, n = 14 slices, 10 mice; Efna3–/–, 114.8 ± 5.0% n = 12 slices, 10 mice, at 55-60 min after 
stimulus, t-test, P = 0.004). (b) Efna3–/– mice had normal tetanus-induced LTP (Efna3+/+, 138.6 ± 
6.0%, n = 13 slices, 10 mice; Efna3–/–, 137.9 ± 7.7% n = 12 slices, 10 mice; at 55-60 min after 
stimulus, t-test, P = 0.9). Insets: representative traces from Efna3+/+ (black) and Efna3–/– (gray) 
mice recorded before (stars) and 55-60 min after (triangles) LTP induction. The stimulation artifacts 
were removed. Error bars, s.e.m. 
______________________________________________________________________________ 
 
2.8 Normal basal synaptic transmission in Efna3 null mutants 
 
To rule out the possibility that the LTP deficit in Efna3–/– mice is caused by 
defects in basal synaptic transmission, I analyzed fiber volley amplitudes, fEPSP 
slopes and PPF. These parameters were comparable in Efna3–/– and Efna3+/+ mice 
(figure 2.10). Moreover, whole-cell patch-clamp analysis did not reveal alterations 
in average frequency and amplitude of miniature excitatory postsynaptic currents 
(mEPSCs) in Efna3 mutant mice (figure 2.11), confirming comparable probability of 
synaptic vesicle release and postsynaptic function in mutant and control mice. 
These data demonstrated that basal synaptic transmission at the CA3-CA1 
synapse is not altered in Efna3–/– mice. 
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Figure 2.10 Normal basal synaptic transmission in Efna3 null mutants. (a) fEPSP slopes at various 
stimulus intensities (FV, fiber volley) and representative traces (Efna3+/+, black; Efna3–/–, gray; n = 
12 slices, 6 mice per group; ANCOVA, P = 0.1). (b) PPF at various ISIs and representative traces 
at 40 ms ISI (Efna3+/+, black; Efna3–/–, gray; n = 10 slices, 5 mice per group, two-way repeated 
measures ANOVA: between genotypes, F1,90 = 0.03, P = 0.9). The stimulation artifacts were 
removed. Error bars, s.e.m. 
______________________________________________________________________________ 
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Figure 2.11 (previous page) Normal mEPSC amplitudes and frequency in Efna3–/– mice. (a) 
Representative traces of mEPSCs in Efna3+/+ and Efna3–/– mice. (b,c) Plots depicting cumulative 
distribution (b) or average values (c) of mEPSC amplitudes showed no alterations in Efna3–/– mice 
compared to wild type controls (b: P = 0.15, two sample Kolmogorov-Smirnov (KS) test; c: P = 0.7, 
t‐test; n=16 mice for Efna3–/– and n=15 mice for the control group). (d,e) Graphs showing the 
cumulative distributions of interevent interval (d) and average frequency (e) of mEPSCs in Efna3+/+ 
and Efna3–/– mice. There were no differences between the two groups (d: P = 0.09, two sample 
KS test; e: P = 0.2, t‐test; n=16 mice for Efna3–/– and n=15 mice for the control group). 97% of 
the total events are shown in (d). Error bars, s.e.m. 
_________________________________________________________________________ 
 
2.9 Astrocytic glutamate transporter upregulation in Epha4 mutants 
 
Since EphA4 forward signaling is dispensable for LTP (Grunwald et al., 
2004), the EphA4 ectodomain may activate ephrinA3 reverse signaling in 
astrocytes, and thereby modulating astrocytic functions that influence LTP. Glial 
glutamate transporters are known to regulate synaptic transmission by clearing 
glutamate from the synapse (Beart and O'Shea, 2007; Tzingounis and Wadiche, 
2007). This property makes them likely candidates for mediating EphA4- and 
ephrinA3-dependent modulation of LTP. For this reason, the abundances of the glial 
glutamate transporters GLAST and GLT1 in brains of Epha4 mutant mice were 
analyzed by western blot. Interestingly, a marked upregulation of GLAST 
abundance and a modest increase in GLT1 abundance were observed in Epha4–/– 
hippocampi and cerebral cortexes compared to littermate controls (figure 2.12a-c). 
Amounts of glial fibrillary acidic protein (GFAP) and the neuronal glutamate 
transporter EAAC1 were not altered in Epha4–/– brains (Figure 2.12a,c), indicating 
that the biochemical alterations were restricted to astrocytes. GLAST upregulation 
was also detected in dissected CA1, but not CA3, regions of CA1-cre;Epha4lx/– 
(figure 2.12d-f).  Similar changes in GLAST and GLT1 abundance were observed 
in Efna3–/– mice (Carmona et al., 2009).  
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Figure 2.12 Increased GLAST and GLT1 protein abundance in Epha4 mutants. (a,b) Western blot 
analysis of GLAST, GLT1, GFAP, EAAC1, EphA4 and tubulin protein levels in cerebral cortexes 
(Cx) and hippocampi (Hip) of Epha4–/– and Epha4+/+ mice. (c) Bar graph depicting average 
amount of glutamate transporters and GFAP in hippocampi of Epha4–/– and Epha4+/+ mice, 
relative to values for Epha4+/+ protein lysates, determined with densitometric measurements. 
Expression was normalized to tubulin. GLAST and GLT1 levels were 50% and 25% higher, 
respectively, in Epha4–/– mice than in Epha4+/+ controls (GLAST, ** P = 0.009, n = 10 mice per 
group; GLT1, * P = 0.03, n = 15 mice; GFAP, P = 0.2, n = 10 mice; EAAC1, P = 0.3, n = 3 mice; 
t-test). (d,e) Western blot analysis of protein lysates from dissected CA1 and CA3 regions 
obtained from CA1-cre;Epha4lx/– mice or Epha4lx/– controls for their content of GLAST and tubulin. 
(f) Bar graph showing average amount of GLAST and GLT1 in the indicated genotypes and 
hippocampal regions. GLAST abundance in CA1, but not CA3, was increased (GLAST in CA1, n = 
7 mice, *** P = 0.0009; GLAST in CA3, n = 6 mice, P = 0.7; GLT1 in CA1, n = 13 mice, P = 0.07; 
GLT1 in CA3, n = 6 mice, P = 0.5). Error bars, s.e.m. Data showed in a-c were generated by S. 
Paixao. Data represented in d-e were generated by S. Paixao and A. Filosa. 
__________________________________________________________________________ 
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Interestingly, the regulation of glial glutamate transporter abundance does 
not happen at the posttranscriptional level, since the levels of Slc1a3 and Slc1a2 
mRNAs, coding for GLAST and GLT1, respectively, in Epha4–/– and Efna3–/– mice 
were similar to control mice (Carmona et al., 2009; Filosa et al., 2009). 
These results revealed that EphA4, presumably by interacting with ephrinA3 
in astrocytes, negatively controls glial glutamate transporter abundance through a 
post transcriptional mechanism. 
 
2.10 Normal astrocytic glutamate transporter abundance in 
Epha4EGFP/EGFP mice 
 
If Epha4 interaction with ephrinA3 induced a reverse signal that causes 
changes of glutamate transporter abundance in astrocytes, the EphA4 intracellular 
domain should be dispensable for this function. To test this hypothesis, glial 
glutamate transporter abundances were examined in brains of Epha4EGFP/EGFP mice, 
in which the cytoplasmic domain is replaced by EGFP (Grunwald et al., 2004). 
Interestingly, western blot analysis did not reveal upregulation of GLAST and GLT1 
suggesting that the EphA4 ectodomain was sufficient for maintaining normal GLAST 
and GLT1 levels in astrocytes (figure 2.13a-c). This observation correlates well with 
the fact that Epha4EGFP/EGFP mice have normal LTP (Grunwald et al., 2004). 
These results indicated that the EphA4 intracellular domain is dispensable 
for regulating glial glutamate transporter abundance. Moreover the data point to 
a role for GLAST and GLT1 in mediating EphA4 and ephrinA3 dependent LTP 
modulation. 
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Figure 2.13 The EphA4 cytoplasmic domain is dispensable for regulating GLAST and GLT1 
abundance. (a,b) Western blot analysis of hippocampal protein lysates from Epha4EGFP/EGFP and 
Epha4+/+ mice for their content of GLAST, GLT1, GFAP, EphA4 and tubulin. (c) Bar graph depicting 
relative abundance of GLAST, GLT1, GFAP and EAAC1 calculated as in Figure 2.12c (n = 7-9 
mice per group, P > 0.3, t-test). Error bars, s.e.m. Data were generated by S. Paixao. 
______________________________________________________________________________ 
 
2.11 Increased glutamate uptake in Efna3–/– astrocytes 
 
The upregulation of glial glutamate transporter abundance observed in 
Epha4 and Efna3 mutant mice (this study and (Carmona et al., 2009)) may result in 
increased glutamate uptake in astrocytes. To test this possibility, whole-cell patch-
clamp recordings from astrocytes in stratum radiatum of Efna3–/– acute 
hippocampal slices were performed. Sodium inward currents associated with 
glutamate uptake in astrocytes were evoked by endogenous release of glutamate 
from presynaptic boutons following stimulation of Schaffer collaterals. The mean 
peak amplitude of normalized transporter currents in response to single pulse 
stimulation was significantly higher in Efna3–/– mice than in littermate controls 
(figure 2.14a,b). Notably, similar results were obtained with a TBS protocol (figure 
2.14c-e) which had produced a much reduced LTP in Efna3–/– mice. 
These results indicated that glutamate uptake in response to a single stimulus 
or a TBS protocol is significantly increased in astrocytes lacking ephrinA3. 
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Figure 2.14 (previous page) Increased astrocytic glutamate transporter currents in Efna3–/– mice. 
(a) Mean inward currents in response to a single pulse stimulation of Schaffer collaterals in 
Efna3+/+ (black) and Efna3–/– mice (gray). Inset: mean fiber volleys (FV) in Efna3+/+ (black) and 
Efna3–/– (gray) mice. (b) Bar graph depicting mean glutamate transporter current amplitudes (TC), 
divided by the amplitude of the corresponding FV to normalize for the numbers of fibers 
activated. Transporter currents in Efna3–/– mice were significantly higher than in Efna3+/+ controls 
in response to a single pulse stimulation (117.7 ± 11.1 pA mV–1 in mutants, n = 42 recordings, 20 
cells; 95.7 ± 8.9 pA mV–1 in Efna3+/+ controls, 34 recordings, 17 cells; ** P = 0.01, t-test) (c) 
Mean inward currents in response to TBS in Efna3+/+ (black) and Efna3–/– mice (gray). Traces are 
averages from all stimulations performed. (d) Bar graph showing mean normalized TC amplidudes 
in response to TBS (124.8 ± 18.8 pA mV–1 in mutants, n = 20 measurements, 15 cells; 83.5 ± 8.5 
pA mV–1 in Efna3+/+ controls, n = 18 measurements, 10 cells; * P = 0.03, t-test). (e) Bar chart 
representing average normalized TC amplitudes in response to each of the ten bursts. Current 
amplitudes were significantly higher in Efna3–/– mice compared to Efna3+/+ controls in 9 out of 10 
bursts (* P < 0.05, t‐test). Stimulation artifacts in a and c were replaced by a vertical line 
indicating the start of the stimulation. Error bars, s.e.m. Data were generated by Silke Honsek 
under the supervision of Christine Rose. 
__________________________________________________________________________ 
 
2.12 Low glutamate concentration near synapses in Epha4–/– mice 
 
Elevated levels of glutamate transporters in astrocytes may decrease 
glutamate levels in proximity of synapses. To estimate synaptic glutamate 
concentrations, I performed whole-cell patch-clamp recordings of CA1 pyramidal 
cells in acute hippocampal slices in presence of the low affinity competitive AMPA 
receptor antagonist -D-glutamylglycine (-DGG). -DGG binds non-NMDA 
receptors with low affinity and with rapid dissociation kinetics comparable to the 
dissociation kinetics of synaptically released glutamate (Liu et al., 1999; Oliet et 
al., 2001). Thus, the degree of inhibition by -DGG is sensitive to the concentration 
of glutamate. If less glutamate is present, the inhibition by -DGG is stronger. 
Whole-cell patch-clamp recordings revealed normal frequencies and average 
amplitude of mEPSCs in Epha4–/– mice compared to Epha4+/+ controls (figure 
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2.15a-e), confirming that basal synaptic transmission was not altered in these 
mutants. -DGG (1 mM) reduced the amplitude of mEPSCs in Epha4–/– slices more 
than the amplitude of mEPSCs in Epha4+/+ control slices (figure 2.15f), indicating 
that the levels of glutamate near synapses in Epha4–/– slices were reduced. 
 
Figure 2.15 Reduced glutamate concentration near synapses in Epha4–/– mice. (a) Representative 
traces of mEPSCs in Epha4+/+ and Epha4–/– mice in absence and presence of 1 mM -DGG. (b,c) 
Graphs depicting cumulative distribution (b) or average (c) of mEPSC amplitudes show no 
alterations in Epha4–/– mice compared to controls (b: P = 0.6, two sample KS test; c: P = 0.4, t‐test; 
n=13 mice per group). (d,e) Graphs showing cumulative distribution of interevent intervals (d) or 
average frequency (e) of mEPSCs reveal no alterations in Epha4–/– mice compared to controls (d: P 
= 0.4, two sample KS test; e: P = 0.3, t‐test; n=13 mice per group). 97% of the total events are 
represented in (d). (f) Inhibitory effect of -DGG on mean mEPSCs amplitude in Epha4–/– mice and 
controls (18.6% ± 2.4% versus 11.6% ± 2.3%, * P = 0.04, t-test; n = 13 mice per group). Error 
bars, s.e.m. 
____________________________________________________________________________ 
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These results suggested that clearance of glutamate near synapses is more 
efficient in Epha4 mutants than in control mice, most likely because of the increased 
amount of glial glutamate transporters in the hippocampus of these mice. 
 
2.13 Reduceded neuronal depolarization during high frequency 
stimulation in Epha4 and Efna3 mutants 
 
I showed that elevated abundance of GLAST and GLT1 in Epha4 and Efna3 
mutants does not alter basal synaptic transmission. However, the increased 
glutamate uptake by astrocytes may cause insufficient postsynaptic depolarization 
during high frequency stimulation protocols used to induce LTP. In this case the 
abundance and activity of glutamate transporters may be important to control the 
amount of glutamate  that escapes from the synaptic  cleft and activates peri- and  
Figure 2.16 Decreased neuronal depolarization during high frequency stimulation in Epha4 and 
Efna3 mutants. (a-c) Bar graphs depicting fEPSP slope 4/slope 1 ratios during a train of four 
stimuli at 100 Hz (0.67 ± 0.07 in CA1-cre;Epha4lx/–, n = 12 slices, 7 mice; 1.07 ± 0.16 in 
Epha4lx/–, n = 14 slices, 7 mice; * P = 0.03; 1.06 ± 0.09 in Efna3–/–, n = 14 slices, 9 mice; 1.51 ± 
0.2 in Efna3+/+, n = 13 slices, 9 mice; * P = 0.05; 0.98 ± 0.14 in CA3-cre;Epha4lx/–, n = 9 slices, 6 
mice; 1.12 ± 0.13 in Epha4lx/–, n = 10 slices, 6 mice; P = 0.5, t-test). Insets: traces from one 
representative train in controls (black) and mutants (gray). Stimulation artifacts were removed. 
Error bars, s.e.m. 
____________________________________________________________________________ 
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extrasynaptic glutamate receptors involved in modulation of neuronal excitability 
and LTP (Lu et al., 1997; Mulholland et al., 2008). Therefore, I analyzed fEPSPs 
during high frequency stimulation in the stratum radiatum of CA1 region of EphA4 
and Efna3 mutants. fEPSP slopes at the end of the first train of each TBS were 
significantly reduced in CA1-cre;Epha4lx/– and Efna3–/– mice compared to those in 
their respective controls (figure 2.16a,b). Postsynaptic depolarization was instead 
not altered in CA3-cre;Epha4lx/– mice (figure 2.16c) that had showed normal TBS-
induced LTP (Figure 2.7c). 
These results demonstrated that neuronal depolarization during high 
frequency stimulation is reduced in CA1-cre;Epha4lx/– and Efna3–/– mice, most likely 
as a consequence of the upregulation of glial glutamate transporters. 
 
2.14 Blockade of glutamate transport rescues LTP defects in EphA4 
and Efna3 mutants 
 
Enhanced clearance of synaptic glutamate by astrocytes is possibly the 
direct cause of the reduced LTP in Epha4 and Efna3 mutant mice. To confirm this 
hypothesis I analyzed the effects of blocking glutamate uptake on LTP by using 
(2S, 3S)-3-{3-[4-(trifluoromethyl) benzoylamino]benzyloxy} aspartate (TFB-TBOA), 
a non-transportable inhibitor that has higher affinity for GLT1 and GLAST than for 
the neuronal transporter EAAC1 (Tsukada et al., 2005). If the LTP impairments 
were due to glutamate transporter upregulation, TFB-TBOA should rescue the LTP 
defects and the difference between mutants and control littermates should 
disappear. Indeed, the application of three TBSs in presence of TFB-TBOA induced 
similar amounts of synaptic potentiation in CA1-cre;Epha4lx/– and Efna3–/– mice 
compared to their respective controls (figure 2.17a,b). Accordingly, the presence of 
TFB-TBOA also allowed normal postsynaptic depolarization during high frequency 
stimulation (figure 2.17c,d). Normal TBS-induced LTP in CA1-cre;Epha4lx/– and 
Efna3–/– mice was also observed  when the broad-spectrum  glutamate transporter  
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Figure 2.17 Rescue of LTP defects in presence of the glutamate transporter inhibitor TFB-TBOA. 
(a,b) TBS-induced LTP in presence of TFB-TBOA (black bar; applied 8 min before TBS and washed 
out 2 min after) in CA1-cre;Epha4lx/– (a) and Efna3–/– (b) mice and respective controls (153.5 ± 
9.1% in CA1-cre;Epha4lx/–, n = 9 slices, 7 mice; 145.2 ± 6.7% in Epha4lx/–, n = 10 slices, 7 mice, P 
= 0.6; 152.6 ± 7.6% in Efna3–/–, n = 11 slices, 9 mice; 149.9 ± 10.1% in Efna3+/+, n = 10 slices, 
9 mice, at 55–60 min after stimulus, P = 0.8, t-test) Insets: representative traces from controls 
(black) and mutants (gray) recorded before (stars) and 55-60 min after (triangles) LTP induction. 
(c,d) Histograms depicting fEPSP slope 4/slope 1 ratios during a train of four stimuli at 100 Hz 
(slope 4/slope 1: 1.23 ± 0.16 in CA1-cre;Epha4lx/–, n = 9 slices, 7 mice versus 1.30 ± 0.08 in 
Epha4lx/–, n = 13 slices, 7 mice, t-test, P = 0.7; 1.24 ± 0.19 in Efna3–/–, n = 12 slices, 8 mice 
versus 1.34 ± 0.12 in Efna3+/+, n = 11 slices, 8 mice, t-test, P = 0.7). Insets: traces from one 
representative train in controls (black) and mutants (gray). Stimulation artifacts were removed. 
Error bars, s.e.m. 
__________________________________________________________________________ 
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inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid (tPDC) (Beart and O'Shea, 2007) 
was used instead of TFB-TBOA (figure 2.18). 
These results suggested that the impaired LTP observed in CA1-cre;Epha4lx/– 
and Efna3–/– mice is largely due to the reduced levels of glutamate near synapses 
during high frequency stimulation, caused by increased glutamate uptake by 
astrocytes. 
 
Figure 2.18 Rescue of LTP defects in presence of the broad spectrum glutamate transporter 
inhibitor tPDC. (a,b) TBS-induced LTP in presence of tPDC (black bar; applied 8 min before TBS 
and washed out 2 min after) in CA1-cre;Epha4lx/– (a) and Efna3–/– (b) mice and respective controls 
(139.3 ± 8.4 % in CA1-Cre; Epha4lx/–, n=13 slices, 9 mice versus 147.9 ± 9.9 % in Epha4lx/–, 
n=12 slices, 9 mice, t-test, P = 0.5, t-test; 147.5 ± 6.3 % in Efna3–/–, n=12 slices, 9 mice versus 
154.0 ± 9.6 % in Efna3+/+, n=13 slices, 9 mice, t-test, P = 0.6, at 55-60 minutes after TBS). Insets: 
representative traces from controls (black) and mutants (gray) recorded before (stars) and 55-60 
min after (triangles) LTP induction. Error bars, s.e.m. 
____________________________________________________________________________ 
 
2.15 Transgenic mice overexpressing ephrinA3 in astrocytes 
 
To obtain further support for ephrinA3 directly regulating the levels of glial 
glutamate transporters, two independent transgenic lines (Tg181 and Tg7047) 
overexpressing ephrinA3 (fused to an hemagglutinin (HA) epitope tag) in glial cells 
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using the glial specific Gfap promoter (Nolte et al., 2001) were generated. 
Immunostaining of P30-60 brain sections from Tg181 mice with an anti-HA 
antibody revealed the typical scattered distribution expected for astrocytes (figure 
2.19a,b). Similar results were obtained with Tg7047 mice (Filosa et al., 2009). HA-
ephrinA3 localization in fine processes of astrocytes was confirmed by 
colocalization of HA-ephrinA3 with GFP in hippocampi of TG181;Gfap-GFP mice 
(Nolte et al., 2001) (figure 2.19c-f).  
These results demonstrated that specific overexpression of ephrinA3 in 
astrocytes could be achieved with the transgenic lines Tg181 and Tg7047. 
 
Figure 2.19 Transgenic mice overexpressing ephrinA3 in astrocytes. (a,b) Anti‐HA 
immunohistochemistry on brain slices from Tg181 mice.  b is a high magnification picture of the 
hippocampus displayed in a. (c-f) Confocal images of hippocampal sections from adult Tg181 
mice crossed to a Gfap-GFP reporter line. Triple labeling for the indicated proteins revealed 
colocalization of HA with GFP but not with the cytoplasmic marker GFAP (f), indicating that the 
transgenic protein is expressed in fine processes of astrocytes. Scale bars: a, 1mm; b, 300 m; c-f, 
10 m. Data were generated by S. Paixao. 
__________________________________________________________________ 
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2.16  EphrinA3 overexpression in astrocytes reduces glial glutamate 
transporter abundance 
 
To investigate the effects of overexpression of ephrinA3 in astrocytes on 
GLAST and GLT1 abundance, hippocampal sections from Tg181 mice were co-
stained with anti-HA and anti-GLAST or anti-GLT1 antibodies (figure 2.20a-c, e-g). 
Areas of high, medium and low HA immunoreactivities were selected and average 
pixel intensities were compared to glial glutamate transporter immunostaining 
intensities. A clear inverse correlation was observed between HA and GLAST or 
GLT1 abundance (figure 2.20d,h). Indeed, areas expressing the highest levels of 
HA-ephrinA3 had significantly lower amounts of GLAST and GLT1. Similar 
reductions of glial glutamate transporter abundance were also observed in line 
Tg7047 which expressed lower levels of transgenic ephrinA3 than line Tg181 
(Filosa et al., 2009), indicating that the phenotypes observed in Tg181 mice were 
not due to positional effects of the transgene and suggesting that modest 
overexpression of ephrinA3 is sufficient to reduce glial glutamate transporter 
expression. 
These results clearly indicated that ephrinA3 in astrocytes negatively 
controls glial glutamate transporter abundance. 
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Figure 2.20 (previous page) EphrinA3 overexpression in astrocytes reduces abundance of glial 
glutamate transporters. (a-c, e-g) Single plane confocal images showing double 
immunefluorescence labeling for GLT1 and HA (a-c) and GLAST and HA (e-g) in the stratum 
lacunosum-moleculare of hippocampal sections obtained from Tg181 mice. Expression of GLT1 and 
GLAST (red) are reduced in areas where the levels of transgenic HA-ephrinA3 (HA, green) are 
high. Scale bars, 10 m. (d,h) Scatter plots showing the negative correlation between GLT1 and 
HA (d) and GLAST and HA (h) relative pixel intensities (GLT1 and HA correlation factor = −0.58, 
n = 280 regions, 3 mice; GLAST and HA correlation factor = –0.46, n = 198 regions, 3 mice, t-
test, P < 0.0001). Red lines in the scatter plots represent linear regression. Data were generated 
by S. Paixao. 
_____________________________________________________________________________ 
 
2.17 EphrinA3 overexpression in astrocytes causes excitotoxicity and 
increases seizure susceptibility   
 
Reduction of glial glutamate transporters has previously been shown to 
increase synaptic glutamate concentrations and to cause neurodegeneration 
(Rothstein et al., 1996; Tanaka et al., 1997). Indeed, excessive amount of 
extracellular glutamate causes excitotoxicity, manifested as formation of dendritic 
focal swellings and spine loss, followed by neuronal death (Greenwood and 
Connolly, 2007). Therefore, mice overexpressing ephrinA3 in astrocytes may have 
signs of excitotoxicity. To analyze neuronal morphology in ephrinA3 transgenic 
mice, intercrosses of Tg181 with a transgenic line (GFP-M) which expresses GFP in 
small neuronal subsets (Feng et al., 2000) were performed. CA1 pyramidal cells 
from P29-31 Tg181 mice showed focal dendritic swellings that were not present in 
neurons of wild type controls (figure 2.21a,b), with variable penetrance possibly 
due to variable expression of the transgene.  
Deficiency in glial glutamate transporters has been associated also with 
epilepsy (Beart and O'Shea, 2007; Maragakis and Rothstein, 2004). For example, 
elimination of GLT1 or GLAST in mice results in increased sensitivity to 
pentylenetetrazole (PTZ)-induced seizures (Tanaka et al., 1997; Watase et al., 
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1998). To verify whether ephrinA3 transgenic mice were more prone to seizures, 
PTZ (45 mg per kg body weight) was injected intraperitoneally and the behavior 
of the mice was monitored. Seizure severity was categorized in four phases, 
according to (Weiergraber et al., 2006). Phase 1 represents a non-convulsive state 
 
Figure 2.21 EphrinA3 
overexpression in astrocytes 
causes excitotoxicity and 
increases susceptibility to 
seizures. (a,b) Confocal 
images of CA1 pyramidal 
neurons from wild type (wt, 
a) and Tg181 (b) mice 
crossed to GFP-M mice. 
Focal dendritic swellings 
are clearly visible in b. 
Scale bar, 50 μm. (c) Bar 
graph showing PTZ-induced 
seizure severity distribution, 
depicted as maximal phase 
reached after 
intraperitoneal injection of 
PTZ, in Tg181 and wt mice. 
Seizure severity was higher 
in Tg181 mice than in wt 
controls (n = 14 mice per 
group, P = 0.01, Mann-
Whitney U-test). (d) Bar 
graph showing mean number of whole body myocloni in phase 3 after injection of PTZ (3.4 ± 0.8 
in wt mice; 8.3 ± 1.4 in Tg181 mice, n = 12 mice per group; t-test, ** P = 0.009). Error bars, 
s.e.m. Data showed in a,b were generated by S. Paixao. Data depicted in c,d were generated by 
Lore Becker and Berend Feddersen under the supervision of Thomas Klopstock. 
__________________________________________________________________________ 
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with reduced motor activity and flat position of the body; phase 3b is 
characterized by whole body myocloni with loss of upright position; phase 3c 
involves complete loss of motor control with wild jumping; phase 4 is characterized 
by generalized tonic-clonic seizures often associated with death due to respiratory 
insufficiency. Interestingly, Tg181 mice displayed increased seizure severity (figure 
2.21c) and more whole-body myocloni (figure 2.21d) after application of PTZ 
compared to controls.  
Taken together, these results suggested that overexpression of ephrinA3 in 
astrocytes causes excitotoxicity and exacerbation of PTZ-induced seizures, most 
likely due to downregulation of glial glutamate transporters. 
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In the last two decades astrocytes have emerged as key regulators of 
synaptic function. Presynaptic bouton, postsynaptic spine and astrocytic process 
constitute a functional unit and the three elements constantly communicate with each 
other. The molecular mechanisms underlying this crosstalk are only partially known. 
Astrocytes can detect the release of neurotransmitters from the presynaptic bouton 
through receptors present on their surface and, in turn, can alter presynaptic and 
postsynaptic activity by releasing gliotransmitters. While there is good knowledge 
of the mechanisms used by the presynaptic bouton to influence astrocyte physiology 
and the signaling systems used by astrocytes to control pre- and postsynaptic 
functions, communication between dendritic spines and astrocytes is poorly 
understood. 
The results presented here show a new mechanism by which the postsynaptic 
spine influences physiology of astrocytes and how these changes, in turn, modulate 
neuronal plasticity. EphA4 in pyramidal cells in CA1 region of the hippocampus 
binds astrocytic ephrinA3 and triggers a signaling cascade into the astrocyte that 
negatively controls the abundance of glial glutamate transporters (figure 3.1). 
Mice lacking EphA4 in CA1 pyramidal cells or ephrinA3 have increased abundance 
of glial glutamate transporters (this study and Carmona et al., 2009), glutamate is 
more efficiently removed during high frequency stimulation and the concentration 
of glutamate near the synapse is reduced (figure 3.1). As a consequence 
postsynaptic depolarization is attenuated and LTP is partially impaired, most likely 
because of limited activation of peri- and/or extrasynaptic glutamate receptors. 
Acute pharmacological inhibition of glutamate uptake allows normal postsynaptic 
depolarization and rescues the LTP defect present in Epha4 and Efna3 mutant mice. 
These results agree with previous reports showing that the neuronal glutamate 
transporter EAAT4 controls long term synaptic plasticity in the cerebellum by 
regulating the activation of perisynaptic mGluRs (Brasnjo and Otis, 2001; Wadiche 
and Jahr, 2005). On the other hand, overexpression of ephrinA3 in astrocytes 
causes  excitotoxicity  and increases  susceptibility to seizures, because of  reduced  
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Figure 3.1 Model describing the function of 
EphA4-ephrinA3 interaction at the neuro-
glia interface.  Top: the binding between 
EphA4 in the dendritic spine (yellow) and 
ephrinA3 on the astrocitic process (orange) 
triggers a negative signal into the astrocyte 
that reduces abundance of GLAST and GLT1. 
The signaling pathway does not converge on 
transcriptional regulation systems and its 
specific nature is still unknown. Center: in 
absence of dendritic EphA4 or ephrinA3 the 
negative pathway controlling GLAST and 
GLT1 abundance is not present and glial 
glutamate transporters are upregulated. This 
causes enhanced glutamate uptake by 
astrocytes that leads to lower concentration of 
glutamate near the synapse, reduced 
postsynaptic depolarization during high 
frequency stimulation and impaired LTP. 
Bottom: Overexpression of ephrinA3 in 
astrocytes reduces the abundance of GLAST 
and GLT1, causing neurodegeneration (focal 
dendritic swellings) and increasing seizure 
susceptibility, possibly because of elevated 
concentration of extracellular glutamate. 
_____________________________________ 
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abundance of glial glutamate transporters and, most likely, increased concentration 
of extracellular glutamate (figure 3.1). 
Considering all the data together a general model emerges in which EphA4-
ephrinA3 interaction at the neuro-glia interface controls a wide spectrum of events: 
physiological regulation of EphA4-ephrinA3 signaling modulates induction and/or 
expression of long term synaptic plasticity; shifting the balance toward 
unphysiological activation of this signaling pathway causes pathological damage to 
the CNS.  
 
3.1 Postsynaptic EphA4 modulates LTP at the CA3-CA1 synapse 
 
EphA4 is present in both pre- and postsynaptic compartments at the CA3-
CA1 synapse (Tremblay et al., 2007). However, I found that only postsynaptic 
EphA4 modulates LTP. The processes of astrocytes can contact both the presynaptic 
bouton and the postsynaptic spine (Ventura and Harris, 1999). Therefore, in 
principle, also presynaptic EphA4 should be able to bind to astrocytic ephrinA3. 
However, glial coverage at hippocampal synapses is asymmetric, with three to four 
fold more glial contact with spines compared to presynaptic boutons (Lehre and 
Rusakov, 2002). It follows that postsynaptic EphA4 is potentially more effective in 
interacting with ephrinA3 present on astrocytes. Moreover, EphA4 is usually 
localized only in the presynaptic bouton or only in the dendritic spine and rarely in 
both compartments at the same synapse (Tremblay et al., 2007). Since a significant 
fraction of synapses in CA1 are not contacted by astrocytic processes (Ventura and 
Harris, 1999), EphA4 pre- or postsynaptic localization could be correlated with the 
astrocyte coverage of the synapse, with presynaptic EphA4 enriched at synapses 
without astrocyte coverage where it could be involved in other functions. 
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3.2 EphA4 and ephrinBs promotes LTP through different mechanisms 
 
The finding that postsynaptic EphA4 modulates LTP at the CA3-CA1 synapse 
argues against the previously proposed model in which presynaptic EphA4 
activates ephrinB reverse signaling in the postsynaptic spine (Grunwald et al., 
2004). Therefore, the modulation of LTP by ephrinB reverse signaling is most likely 
independent of EphA4 action. Presynaptic EphB receptors could be responsible for 
activating ephrinBs in the postsynaptic spine (Grunwald et al., 2001).  
Alternatively, ephrinBs and EphA4 could modulate synaptic plasticity by 
interacting in cis in the postsynaptic membrane. However, this is an unlikely scenario 
for two reasons. First, the only cis interaction between an Eph receptor and an 
ephrin that has been described so far leads to inhibition of the receptor forward 
signaling (Carvalho et al., 2006). Instead, in the situation described here the cis 
interaction should activate ephrinB reverse signaling since Efnb2 and Efnb3 mutant 
mice display impaired LTP at the CA3-CA1 synapse (Bouzioukh et al., 2007; 
Grunwald et al., 2004). Second, Efnb2 mutants display LTP defects following 
application of both TBS and tetanus (Bouzioukh et al., 2007), while here I showed 
that only TBS-induced LTP is impaired in Epha4 mutant mice. 
EphA4 promotes also LTD in a forward signaling independent manner 
(Grunwald et al., 2004). It is possible that EphA4 regulates LTP and LTD with 
different mechanisms and presynaptic EphA4 could be important for promoting LTD 
by activating postsynaptic ephrinB reverse signaling. It will be crucial to analyze 
LTD in Efna3 null mutants to verify this hypothesis. If Efna3 mutants will show normal 
LTD, EphA4 must regulate LTP and LTD through divergent mechanisms. 
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3.3 LTP induced by diverse stimulation patterns is differently affected 
by EphA4-ephrinA3 signaling  
 
Epha4 and Efna3 mutant mice display defective LTP when induced with TBS 
but not with tetanus. This difference could be explained by the kinetic properties of 
glutamate uptake. The tetanic stimulation utilized in the experiments described here 
consists of 100 stimuli given at a frequency of 100 Hz. TBS is characterized by 
short bursts (four stimuli) of high frequency stimulation separated by 160 ms 
intervals. The increased abundance of glial glutamate transporters in Epha4 and 
Efna3 mutants could affect clearance of glutamate released in response to short 
bursts of stimuli applied during TBS, but could not be sufficient to significantly alter 
the dynamics of glutamate released during longer trains of stimuli, such as in case 
of a tetanus (Diamond and Jahr, 2000). The finding that glutamate uptake during 
TBS is more efficient in astrocytes lacking ephrinA3 than in controls supports this 
hypothesis. 
 
3.4 Does EphA4-ephrinA3 interaction control metaplasticity? 
 
The increased glutamate uptake from astrocytes and the potentially 
reduced activation of perisynaptic glutamate receptors in Epha4 and Efna3 mutants 
could have more profound effects on modulation of long term synaptic plasticity. 
EphA4-ephrinA3 interaction could contribute to metaplastic control of the system by 
regulating intrinsic neuronal excitability and thereby changing the threshold for LTP 
induction. It has been shown that activation of perisynaptic mGluRs controls 
metaplasticity at the CA3-CA1 synapse (Ireland and Abraham, 2002; van Dam et 
al., 2004), possibly by affecting phosphorylation and surface expression of 
voltage-gated potassium channels (Hu et al., 2007; Kim et al., 2007). This type of 
regulation could affect the overall exitability of the neuron or could be limited to 
specific dendritic branches. Experiments are under way to investigate a possible 
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link between regulation of glial glutamate transporter abundance, activation of 
mGluRs and regulation of intrinsic neuronal excitability in Epha4 and Efna3 mutant 
mice.  
 
3.5 Does EphA4-ephrinA3 interaction regulate plasticity of glutamate 
uptake? 
 
The data presented here demonstrate that neuronal control of glial 
glutamate uptake can modulate long term synaptic plasticity at the CA3-CA1 
synapse. These findings are consistent with previous observations showing that 
changes in glutamate uptake parallel changes in synaptic strength in both 
vertebrates and invertebrates (Genoud et al., 2006; Levenson et al., 2002; Pita-
Almenar et al., 2006). For example, LTP induction at the CA3-CA1 synapse has 
been shown to trigger long term enhancement of glial glutamate uptake through 
increased expression of GLT1 via a PKA-dependent mechanism (Pita-Almenar et 
al., 2006). EphA4-ephrinA3 signaling is an excellent candidate for mediating 
regulation of glial glutamate uptake by neuronal activity. EphA4 in the dendritic 
spine, by binding ephrinA3 on astrocytes, possibly keeps the abundance of glial 
glutamate transporters at a relatively low level. Induction of LTP could induce a 
reduction of binding between EphA4 and ephrinA3, for example by triggering 
internalization of the receptor or by promoting the binding of antagonists to 
EphA4. This mechanism could potentially lead to synaptic-specific enhancement of 
glial glutamate uptake. 
 
3.6 Possible molecular mechanisms mediating ephrinA3 control of 
glial glutamate transporter abundance 
 
Activation of ephrinA3 reverse signaling in the astrocyte negatively controls 
abundance of glial glutamate transporters through a posttranscriptional mechanism 
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(data presented in this thesis and in Filosa et al., 2009). There are several other 
mechanisms by which ephrinA3 could control the abundance of glial glutamate 
transporters. EphrinA3 activation could repress translation of the mRNAs coding for 
GLAST and GLT1. However, Carmona et al. found that stimulation of ephrinA3 with 
preclustered EphA receptor fusion proteins in acute hippocampal slices decreases 
the amount of glial glutamate uptake in only two hours (Carmona et al., 2009). If 
ephrinA3 controlled translation of glial glutamate transporters, the half life of 
GLAST and GLT1 must be very short to account for the rapid downregulation of 
glutamate uptake from astrocytes observed in those experiments. Alternatively, 
ephrinA3 could control internalization and degradation of the two proteins. It has 
been shown that activation of different kinases, including PKA, PKC and PI3K can 
regulate internalization and degradation of glial glutamate transporters (Adolph 
et al., 2007; Gonzalez and Robinson, 2004; Guillet et al., 2005). EphrinA3 
activation by neuronal EphA4 is a potential trigger for these molecular pathways. 
The involvement of different kinases downstream of ephrinA3 could in the future be 
demonstrated by analyzing GLAST and GLT1 abundance in acute hippocampal 
slices after stimulation of ephrinA3 reverse signaling in presence of specific kinase 
inhibitors. 
Another important question to address in the future is how ephrinA3 can 
induce intracellular signaling into the astrocyte without having a cytoplasmic 
domain. Two mechanisms have been proposed to be used by GPI-anchored 
ephrinAs to initiate intracellular signaling cascades: interaction with a 
transmembrane protein (coreceptor) (Lim et al., 2008b; Marler et al., 2008), 
similarly to GDNF receptors (Airaksinen and Saarma, 2002); modification of the 
local physical properties of the plasma membrane that triggers recruitment and 
activation of Src family kinases (Davy et al., 1999). The first hypothesis could be 
tested by using a candidate approach analyzing interactions between ephrinA3 
and known coreceptors of ephrinAs, or by using unbiased proteomic or cell 
screening methods. The second hypothesis could be more easily tested by 
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analyzing abundance of glial glutamate transporters after ephrinA3 activation in 
presence of Src family kinases inhibitors. 
 
3.7 Could there be a link between synaptic plasticity and dendritic 
spine morphology defects in Epha4 and Efna3 mutant mice? 
 
Activation of EphA4 forward signaling has been shown to regulate dendritic 
spine morphogenesis (Bourgin et al., 2007; Carmona et al., 2009; Fu et al., 2007; 
Murai et al., 2003). Since changes of spine morphology are correlated to changes of 
synaptic strength (Alvarez and Sabatini, 2007), the possibility exists that the LTP 
defect observed in Epha4 and Efna3 mutant mice could be a secondary effect caused 
by alterations of spine shape. However, the role of EphA4 in LTP is independent of 
forward signaling (Grunwald et al., 2004) and distinct from its role in spine 
morphogenesis. Moreover, the Epha4 conditional knock out described here did not 
show alterations in spine length, width and density (Sonia Paixao, personal 
communication), possibly due to the late onset of Cre activity [second postnatal week 
in the CA1-Cre line (Tsien et al., 1996)]. Therefore, the LTP defect and the alteration 
of spine morphology are distinct phenotypes and the latter does not influence the 
former. On the other hand, dendritic spine shape and size are strongly dependent on 
the strength of synaptic connections (Alvarez and Sabatini, 2007). Thus, defects in long 
term synaptic plasticity may influence the morphology of dendritic spines in Epha4 and 
Efna3 mutants. 
 
3.8 Does EphA4-ephrinA3 interaction control morphology and/or 
motility of astrocytic processes? 
 
The small processes of astrocytes that contact synapses are highly motile 
and the astrocyte coverage of the synapse can vary depending on the activity of 
neuronal connections and the physiological status of the entire organism (Genoud et 
al., 2006; Oliet and Piet, 2004). For example, increased synaptic activity in the 
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barrel cortex of mice produced by sensory stimulation induces an increase of 
astrocytic envelopment of excitatory sinapses (Genoud et al., 2006). In the 
supraoptic nucleus of the hypothalamus astrocytic processes undergo dramatic 
morphological changes depending on the physiological status of the organism 
(Oliet and Piet, 2004). These changes alter glial coverage of synapses and 
consequently impact on synaptic physiology through alterations of glial glutamate 
uptake and modulation of synaptic NMDARs by astrocyte-released D-serine (Oliet 
et al., 2001; Panatier et al., 2006). 
It has been recently suggested that EphA-ephrinA interaction at the neuro-
glia interface regulates motility of small astrocytic protrusions (Nestor et al., 2007). 
This process can possibly occur in parallel with the regulation of glial glutamate 
transporter abundance. The two events could act synergistically to modulate 
synaptic function by regulating glutamate uptake. In accord with this model, it has 
been shown that sensory stimulation induces changes in both expression of glial 
glutamate transporters and glial coverage of synapses in the barrel cortex of mice 
(Genoud et al., 2006). In vivo imaging of astrocytic processes during sensory 
stimulation in Epha4 and Efna3 mutant mice could confirm this hypothesis.  
 
3.9 Potential pathological consequence of EphA4-ephrinA3 signaling 
malfunction 
 
Alterations of astrocyte physiology, including dysfunction of astrocyte 
glutamate uptake, have been implicated in many pathological conditions affecting the 
CNS (Beart and O'Shea, 2007; Seifert et al., 2006). For example, several studies 
have suggested a link between glutamate uptake malfunction and epilepsy. Mice 
lacking GLT1 display spontaneous seizures and lower threshold for PTZ-induced 
seizures (Tanaka et al., 1997). Similarly, pharmacological inhibition of GLT1 reduces 
the threshold for evoking epileptiform activity in rats (Campbell and Hablitz, 2004; 
Demarque et al., 2004). Reduced or dysfunctional glial glutamate transporters may 
also be involved in seizure initiation and/or propagation in patients affected by 
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epilepsy (During and Spencer, 1993; Mathern et al., 1999; Proper et al., 2002). 
Moreover, reduced glutamate uptake can lead to neurodegeneration caused by 
excitotoxicity (Rothstein et al., 1996). In agreement with these evidences, the data 
presented here show that overexpression of ephrinA3 in astrocytes in vivo causes 
excitotoxicity and increased susceptibility to seizures by reducing abundance of glial 
glutamate transporters and possibly by increasing the concentration of extracellular 
glutamate. Pyramidal neurons in ephrinA3 overexpressing mice have dystrophic 
dendrites with focal swellings and loss of dendritic spines typically present in neural 
tissue exposed to excitotoxic conditions in vitro (Hasbani et al., 2001; Oliva et al., 
2002; Swann et al., 2000) and possibly in humans affected by epilepsy (Swann et al., 
2000). Furthermore, administration of the convulsive drug PTZ induces more easily 
seizures in ephrinA3 overexpressing mice than in control animals. It would be 
interesting to screen for mutations in loci coding for Eph receptors and ephrins in 
patients affected by epilepsy to investigate a possible direct involvement of Eph-
ephrin signaling in this pathological condition. 
Reduced expression of glial glutamate transporters has been linked also to 
ALS. Patients affected by ALS present impaired glutamate uptake and reduced 
amounts of GLT1 (Rothstein et al., 1992; Rothstein et al., 1995; Sasaki et al., 2000). 
Rodents carrying a mutant form of the Cu/Zn superoxide dismutase (SOD1) found in 
some patients with familial ALS reproduce many of the aspects of the disease, 
including loss of GLT1 (Howland et al., 2002; Trotti et al., 1999). Interestingly, it was 
recently found that the VAMP-associated membrane protein B (VAPB), one of the 
proteins mutated in some forms of familial ALS, binds to Eph receptors and modulates 
their signaling (Tsuda et al., 2008). It would be interesting in the future to investigate a 
possible link between VAPB-mediated regulation of Eph-ephrin signaling and 
expression of glial glutamate transporters. Moreover, assessment of motor neuron loss 
in ephrinA3 overexpressing mice could reveal a more direct link between EphA4-
ephrinA3 signaling dysfunction and ALS. 
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4.1 Materials 
 
4.1.1 Chemicals and drugs 
Chemicals were purchased from Biomol, Merck, Roth and Sigma. Enzymes and 
relative buffers were purchased from New England Biolabs (NEB) or Roche. Kits for 
plasmid purifications and gel-extractions were purchased from Quiagen. Drugs for 
electrophysiology experiments were purchased from Tocris. All water used to 
prepare solutions was filtered with the Milli-Q-Water System (Millipore).  
 
4.1.2 Genotyping oligonucleotides  
All oligonucleotides were synthesized by Metabion. 
 
EphA4wtF               5’–CAATCCGCTGGATCTAAGTGCCTGTTAGC–3’ 
EphA4wtR               5’–ACCGTTCGAAATCTAGCCCAGT–3’ 
EphA4koF                5’–GACTCTAGAGGATCCACTAGTGTCGA–3’ 
EphA4koR              5’–TTTTCTCCCTCTTTAAGCAAGGATCAAGC–3’ 
Cre1                       5’–GCCTGCATTACCGGTCGATGCAACGA–3’ 
Cre2                       5’–GTGGCAGATGGCGCGGCAACACCATT–3’ 
Thy1F                      5’–TCTGAGTGGCAAAGGACCTTAGG–3’ 
Thy1R                    5’–CGCTGAACTTGTGGCCGTTTACG–3’ 
EphrinA3wtF            5’–GGGGTGTCTGAGAGAAGCTG–3’ 
EphrinA3wtR            5’–CGACATCTCTGCCTTCTTCC–3’ 
EphrinA3koF            5’–GATGGCGTCGACGATAACTT–3’ 
EphrinA3koR            5’–AAGTCGTGCTGCTTCATGTG–3’ 
LacZF                     5’–CCAGCTGGCGTAATAGCGAA–3’ 
LacZR                    5’–CGCCCGTTGCACCACAGATG–3’ 
GFAPF                   5’–CAGAGCAGGTTGGAGAGGAG–3’ 
GFAP-GFPR            5’–GGTCTTGTAGTTGCCGTCGT–3’ 
GFAP-A3R              5’–GCGGGCAGTAAATATCCAGA–3’ 
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4.1.3 Primary antibodies 
       
 
Antibody Species Source Dilution Application 
 
 
-digoxygenin 
(AP conjugated) Sheep Roche 1:2000 ISH 
 
 
-EAAC1 Mouse monoclonal Chemicon 1:500 WB 
 
 
-EphA4 (a-Sek) Mouse monoclonal 
Becton 
Dickinson 1:1000 WB 
 
 
-EphA4  Rabit polyclonal,  In house 1:1000 WB 
 
 
(intracellular 
domain) serum 1383        
 
 
-EphA4   Rabbit polyclonal,  
(Egea et al., 
2005) 1:1000 WB 
 
 
(globular domain) serum 1078        
 
 
-GFAP Rabit polyclonal DAKO 1:1000 IF, IHC, WB 
 
 
-GFAP Mouse monoclonal Sigma 1:1000 WB 
 
 
-GFP Rabit polyclonal RDI 1:1000 IF 
 
 
-GFP Mouse monoclonal 
Molecular 
Probes 1:2000 IF 
 
 
-GLAST  Rabit polyclonal Frontier Science 1:5000 IF 
 
 
-GLAST  
Guinea pig 
polyclonal Chemicon 1:5000 WB 
 
 
-GLT1  
Guinea pig 
polyclonal Chemicon 
1:2000-
1:5000 IF, WB 
 
 
-hemagglutinin  Rat monoclonal,  Sigma 
1:1000-
1:2000 IF, WB 
 
 
  clone 3F10       
 
 
-tubulin Mouse monoclonal,  Sigma 1:50000 WB 
 
 
  clone DM 1A        
 
       
       
       Table 4.1 Summary of the primary antibodies used for the experiments described in this 
thesis. Abbreviations: AP, alkaline phosphatase; IF, immunofluorescence; IHC 
immunohistochemestry; WB, western blot; , anti. 
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4.1.4 Buffers and solutions 
 
General purpose buffers and solutions 
 
PBS (phosphate-buffered saline) 
10× stock solution, 1 liter:                           Working solution, pH 7.3: 
80 g NaCl                                               137 mM NaCl 
2 g KCl 2.7 mM KCl 
11.5 g Na2HPO4·7H2O                             4.3 mM Na2HPO4·7H2O 
2 g KH2PO4 1.4 mM KH2PO4 
 
4% PFA (Paraformaldeyde)  
For 50 ml: 
PFA               2 g 
5M NaOH      10 l  
H2O             45 ml at 70 ºC 
 
As soon the solution was clear 5 ml of 10X PBS were added. After 2-3 minutes at 
70 ºC the solution was cooled down on ice. 
 
Solutions for molecular biology 
 
Gel loading buffer 
Glycerol          25 ml 
50X TAE          1 ml 
Orange G        0.1 g 
H2O                24 ml 
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TE (Tris/EDTA) buffer 
10 mM Tris·Cl, pH 8.0 
1mM EDTA, pH 8.0 
 
TAE (Tris/acetate/EDTA) buffer 
50× stock solution:                                  Working solution, pH 8.5: 
242 g Tris base                                       40 mM Tris·acetate 
57.1 ml glacial acetic acid                        2 mM Na2EDTA·2H2O 
37.2 g Na2EDTA·2H2O 
H2O up to 1 liter 
 
Embedding solutions for vibratome sectioning 
 
0.1 M Acetate buffer, pH 6.5 
1 M Sodium acetate       99 ml 
1 M Acetic Acid             960 l 
H2O                             up to 1 liter 
 
Embedding solution 
a) Ovalbumin (Sigma, Cat.# A-S253)          90 g 
0.1 M Acetate buffer                            200 ml 
Ovalbumin was dissolved in acetate buffer (stirring overnight) at room 
temperature. The solution was then filtered through a gaze in order to remove 
undissolved albumin and air bubbles. 
b) Gelatin                                              15 g 
0.1 M Acetate buffer                            100 ml 
Gelatin was dissolved in warm acetate buffer. The solution was cooled down to 
room temperature and (a) and (b) were mixed. Aliquots of the final solution were 
stored at –20 ºC. 
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Solutions for in situ hybridization 
 
Blocking solution 
For 10 ml: 
5X MAB, pH 7.5                                                            2 ml 
Blocking reagent (Roche, Cat.# 1096 176)                        200 g 
Sheep serum                                                                 2 ml 
H2O                                                                             up to 10 ml 
 
Deionized formamide 
Ion-exchange resin (Biorad, Cat.# 142–6425)                   25 g 
Formamide                                                                    500 ml 
 
Stirred for 45 minutes, filtered and stored (50 ml aliquots) at –20 ºC. 
 
Developing solution 
For 10 ml: 
BCIP (5-Bromo-4-chloro-3-indolyl phosphate, Sigma)          11 l 
NBT (4-nitroblue tetrazolium chloride, Sigma)                     14 l 
NTMT                                                                           10 ml 
  
Hybridization solution 
For 50 ml: 
Deionized Formamide                                                     25 ml 
20X SSC, pH 4.5                                                            12.5 ml 
Tween-20                                                                     100 l 
5% Chaps                                                                     5 ml 
Blocking reagent (Roche, Cat.# 1096 176)                        1 g 
10 mg/ml tRNA                                                             250 l 
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50 mg/ml Heparin                                                         50 l 
0.5 M EDTA, pH8.1                                                        500 l 
H2O                                                                             up to 50 ml 
 
5X MAB (maleic acid buffer), pH 7.5 
For 1 liter: 
Maleic acid                       58 g 
NaCl                                44 g 
H2O                                 up to 800 ml 
NaOH pellets                    35 g 
H2O                                 up to 1 liter 
 
MABT 
1X MAB 
0.2% Tween-20 
 
NTMT 
For 200 ml: 
5 M NaCl                        4 ml 
1 M Tris, pH 9.5               20 ml 
1 M MgCl2                      10 ml 
Tween-20                        200 l (0.1%) 
H2O                                up to 200 ml 
 
PBT (PBS Tween) 
0.1% Tween-20 in PBS 
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Solution 1 
For 10 ml: 
Deionized formamide        5 ml  
20X SSC, pH4.5               2.5 ml 
20% Tween-20                100 l 
5% Chaps                        1 ml 
H2O                                 up to 10 ml 
 
Solution 2 
For 10 ml: 
Deionized formamide         5 ml  
20X SSC, pH4.5                1 ml 
20% Tween-20                 100 l 
5% Chaps                        200 l 
H2O                                 up to 10 ml 
 
Solution 3 
For 10 ml: 
20X SSC, pH4.5                 1 ml 
20% Tween-20                  100 l 
5% Chaps                         200 l 
H2O                                  up to 10 ml 
 
20X SSC (sodium chloride/sodium citrate), pH 4.5 
For 1 liter: 
Sodium citrate                    69.2 g 
Citric Acid                         13.7 g 
NaCl                                175 g 
H2O                                  up to 1 liter 
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Solutions for electrophysiology recordings 
 
ACSF1 (artificial cerebrospinal fluid for extracellular field recordings and 
neuron patch-clamping) 305-315 mosm/Kg, pH 7.4 
For 1 liter: 
NaCl                                7.25 g (124 mM) 
KCl                                  0.22 g (3 mM) 
NaH2PO4                         0.17 g (1.25 mM) 
CaCl2                              0.37 g (2.5 mM) 
MgSO4                            0.50 g (2 mM) 
NaHCO3                          2.18 g (26 mM) 
Glucose                           1.98 g (10 mM) 
H2O                                 up to 1 liter 
 
The solution was saturated with 95% O2 and 5% CO2. 
 
ACSF2 (artificial cerebrospinal fluid for astrocyte patch-clamping) 
For 1 liter: 
NaCl                                 7.31 g (125 mM) 
KCl                                   0.18 g (2.5 mM) 
NaH2PO4                          0.17 g (1.25 mM) 
CaCl2                               0.30 g (2 mM) 
MgCl2                              0.095 g (1 mM) 
NaHCO3                           2.18 g (26 mM) 
Glucose                            3.96 g (20 mM) 
H2O                                 up to 1 liter 
 
The solution was saturated with 95% O2 and 5% CO2. 
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Internal solution 1 (internal solution for neuron patch-clamping) 280 mosm/Kg, 
pH 7.2 
For 50 ml: 
CsGluconate                      (2.94 ml gluconic acid + 1.8 ml CsOH) (150 mM) 
HEPES                              119 mg (10 mM) 
MgATP                             51 mg (2 mM) 
EGTA                               3.8 mg (0.2 mM) 
NaCl                                23 mg (8 mM) 
H2O                                 up to 50 ml 
 
Aliquots were stored at –20 ºC. 
 
Internal solution 2 (internal solution for astrocyte patch-clamping, pH 7.30) 
For 50 ml: 
KCH3SO3                           805 mg   (120 mM) 
KCl                                   0.141 mg (32 mM) 
HEPES                               119 mg (10 mM) 
NaCl                                11.5 mg (4 mM) 
MgATP                             102 mg (4 mM) 
NaGTP                             11 mg (0.4 mM) 
H2O                                  up to 50 ml 
 
4.1.5 Mouse lines 
 
Camk2a‐cre transgenic mice were generated by Liliana Minichiello in our research 
group (Minichiello et al., 1999) 
 
Efna3–/– mice were generated by the company Ozgene for Elena B. Pasquale’s 
laboratory (Carmona et al., 2009). 
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Epha4–/– mice were generated in Andrew W. Boyd laboratory (Dottori et al., 
1998) and maintained on a mixed 129xC57Bl/6 background. 
 
Epha4lx/lx mice were generated by Klas Kullander in collaboration with the 
transgenic service of the Max Planck Institute for Neurobiology (Klas Kullander, 
unpublished results and (Filosa et al., 2009)). Briefly, EphA4 cDNA flanked with 
loxP sites was inserted into exon 3 of the EphA4 gene by homologous 
recombination in embryonic stem cells. Recombinant clones were injected into mouse 
blastocysts to obtain chimaeric mice transmitting the mutated allele through the 
germ line. The neomycin resistance gene was removed by crossing heterozygous 
Epha4lx/+ mice with deleter-FlpE mice (Rodriguez et al., 2000). Mice were 
maintained in a mixed 129xC57Bl/6 background. 
 
Gfap-Efna3 transgenic mice were generated by Sonia Paixao (Filosa et al., 2009). 
Briefly, Efnb2 cDNA in the pJK38 vector (Lauterbach and Klein, 2006) was 
replaced by the human Efna3 cDNA (from nucleotide 137 to 787, GenBank 
accession number NM_004952.4), EYFP was then removed and the pCMV 
promoter was replaced by the human glial specific Gfap promoter (Nolte et al., 
2001). The ApaLI/DraIII fragment containing the Efna3 transgene was isolated by 
electroelution and purified with Elutip-D minicolumns (Schleicher & Schüll). Oocytes 
from FVB mice were injected using conventional microinjection technology. Founder 
lines were mated with C57BL/6 mice and maintained on a mixed FVBxC57Bl/6 
background. 
 
Gfap-GFP transgenic mice were generated in Frank Kirchhoff laboratory (Nolte et 
al., 2001). 
 
Grik4-cre (CA3-cre) knock-in mice were generated by York Rudhard in Ralf 
Schoepfer’s laboratory (Filosa et al., 2009). Briefly, a YAC containing the Grik4 
gene modified to carry a targeting cassette in the 3’ untranslated region of Grik4 
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was used for homologous recombination in embryonic stem cells. The targeting 
cassette consisted of an IRES element, EGFP-Cre and frt-flanked selection markers 
neo and his3 which were removed by crossing CA3-cre mice with Flp deleter mice 
(Rodriguez et al., 2000). 
 
PGK-cre transgenic mice were generated in Peter Lonai’s laboratory (Lallemand et 
al., 1998).  
 
R4Ag11CaMKII-cre (CA1-cre) transgenic mice were generated in Susumu 
Tonegawa’s laboratory (Tsien et al., 1996). 
 
Thy1-GFP transgenic mice were generated in Joshua R. Sanes’s laboratory (Feng et 
al., 2000). 
 
4.2 Methods 
 
4.2.1 Molecular biology  
 
Tail DNA preparation and genotyping 
Tail biopsies (1-3 mm) were taken from mice and incubated at 95 °C three times 
for 15 min in 100 l of 50 mM NaOH and vortexed thoroughly between heating 
steps. Samples were then centrifuged to precipitate the remaining debris and the 
mix was neutralized with the addition of 10 l 1.5 M Tris-HCl, pH 8.8 and stored 
at 4 °C. 1-2 l of DNA were used as template for polymerase chain reaction 
(PCR). PCR was carried out in a total volume of 50 l and contained 2.5 mM 
dNTPs, 50mM specific primers, 1X PCR buffer (NEB) and 0.5 l of Taq polymerase 
(NEB). The primers and the PCR programs used for the amplification of specific 
alleles are summarized in table 4.2.  
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Agarose gel electrophoresis  
Gels with 1% agarose in TAE with 3 l ethidium bromide/100 ml TAE were used. 
Warm gels were poured into a chamber containing combs. Once the gel had 
solidified the combs were removed and the gel submerged in 1X TAE in an 
electrophoresis chamber. PCR products, RNA probes or products of enzymatic 
digestions were loaded into the wells together with gel loading buffer (10:1) and 
separated according to their size for 20-30 min at ~200V. DNA or RNA was 
visualized under UV light using a gel documenting system (BioRad). 
Allele Primers Step 1 Step 2 Step 3 Step 4 Step 5 Step 6
Epha4 wt
EphA4wtF    
+    
EphA4wtR 
2 min 
@ 
95ºC
30 s    
@ 
95ºC 
1 min 30 
s @ 68ºC 
1 min 15 
s @ 72ºC 
30X    
step 2 - 
4
6 min 
@ 
72ºC 
Epha4 ko
EphA4koF    
+    
EphA4koR
3 min 
@ 
94ºC
1 min 
@ 
94ºC
1 min      
@ 65ºC
1 min      
@ 72ºC
37X    
step 2 - 
4
20 min 
@ 
72ºC 
Epha4 lx
LacZF          
+         
LacZR
5 min 
@ 
95ºC
30 s    
@ 
95ºC
30 s        
@ 58ºC
30 s        
@ 72ºC
35X    
step 2 - 
4
5 min 
@ 
72ºC 
Efna3 wt
EphrinA3wt
F +     
EphrinA3wt
R
5 min 
@ 
95ºC
30 s    
@ 
95ºC
30 s        
@ 63ºC
30 s        
@ 72ºC
35X    
step 2 - 
4
5 min 
@ 
72ºC 
Efna3 ko
EphrinA3ko
F +     
EphrinA3ko
R
2 min 
@ 
95ºC
1 min 
@ 
95ºC
1 min @ 
64ºC
1 min      
@ 72ºC
35X    
step 2 - 
4
2 min 
@ 
72ºC 
Cre
Cre1 + 
Cre2
3 min 
@ 
94ºC
1 min 
@ 
94ºC
1 min @ 
67ºC
1 min      
@ 72ºC
35X    
step 2 - 
4
5 min 
@ 
72ºC 
GFAP-HA-A3
GFAPF         
+          
GFAP-A3R
5 min 
@ 
95ºC
30 s    
@ 
95ºC
30 s        
@ 61ºC
45 s        
@ 72ºC
40X    
step 2 - 
4
X
GFAP-eGFP
GFAPF         
+          
GFAP-GFPR
5 min 
@ 
95ºC
30 s    
@ 
95ºC
30 s        
@ 59ºC
30 s        
@ 72ºC
35X    
step 2 - 
4
X
Thy1-GFP
Thy1F          
+         
Thy1R
5 min 
@ 
95ºC
30 s    
@ 
95ºC
30 s        
@ 60ºC
1 min      
@ 72ºC
35X    
step 2 - 
4
3 min 
@ 
72ºC 
Table 4.2 Summary of the primers and PCR programs used to amplify the indicated 
alleles. 
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Transformation of competent E.coli by electroporation  
50 l of competent bacteria (DH5, Invitrogen) were thawed on ice and 0.2-2 l 
of plasmid DNA were added. The mix was transferred into a sterile, pre-chilled 
0.2 cm electroporation cuvette. One electric pulse was applied to the cuvette with 
the pulser apparatus set to 25 F and 2.5 kV; the pulse controller to 200 Ω. 1 ml 
of LB medium was immediately added to the cells, which were then transferred to a 
plastic tube and shaken for 60 min. The bacteria were then plated on LB plates 
containing ampicillin and grown over night at 37 °C.  
 
Preparation of plasmid DNA  
Plasmid DNA was purified from large scale (500ml, maxipreparation) bacterial 
cultures. Single colonies of transformed bacteria were picked from LB plates 
containing ampicillin and inoculated into flasks containing LB medium with 100 
g/ml ampicillin and grown overnight shacking at 37 °C. Harvesting and 
purification of maxipreparation was carried out according to Qiagen protocol 
using Qiagen buffers. The DNA concentration was measured in a UV spectrometer 
at 260 nm.   
 
Molecular Cloning 
A pcDNA3 vector containing Epha4 cDNA was modified in order to obtain a vector 
containing an Epha4 cDNA fragment extending from nucleotide 880 to 1551 
(GenBank accession number NM_007936). The original vector was digested with 
the restriction enzymes BamHI and HindIII. The digested products were separated 
by agarose gel electrophoresis and the band corresponding to the fragment 
containing the backbone vector together with the cDNA portion of interest was cut 
out from the gel. The DNA was purified by using the QIAquick gel extraction kit 
(Quiagen). 50 ng of the purified DNA were incubated over night in 10 l of 1X T4 
ligase buffer solution with 1 l of T4 ligase and 1 mM ATP. The circularized DNA 
was precipitated by adding 1 l of 3M NaAcetate, 1 l of glycogen and 30 l of 
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ethanol to the ligase solution (cooled on dry ice) and by centrifuging the solution at 
13000 rounds per minute (rpm) for 10 min. The pellet was washed twice with 100 
l of ethanol, centrifuged at 13000 rpm for 2 min, then dried and finally dissolved 
in 10 l of water. 
 
Generation and labeling of antisense RNA probes  
10 g of plasmid DNA were linearized by digesting it for 3 h at 37 °C with the 
restriction enzyme XhoI. After purification with phenol/chloroform extraction, 2 l 
of the linearized DNA were incubated with 2 l transcription buffer (Roche, in situ 
probe labeling kit), 2 l of 0.1M DTT, 2 l digoxigenin-conjugated dNTPs, 1 l 
RNAse inhibitor and 1 l of the specific RNA polymerase in a total volume of 20 l 
for 3 h at 37 °C. Then, 10 l of 4 M LiCl, 100 l TE and 300 l of ethanol were 
added to the mix and incubated for 30 min at –20 °C. Subsequently, the mix was 
centrifuged for 20 min at 4 °C. The pellet was washed with 70% ethanol, dried on 
ice and then dissolved in 100 l TE. Aliquots were stored at –20 °C. For in situ 
hybridization 20-30 l of RNA probe solution were used per ml of hybridization 
buffer.  
 
4.2.2 Biochemistry 
  
Tissues were homogenized in ice-cold buffer (50 mM Tris–HCl, pH 7.4, 150 mM 
NaCl, 1% Triton X-100) containing protease and phosphatase inhibitor cocktail 
tablets (Roche). The protein extracts were separated by SDS-PAGE and probed by 
immunoblotting with primary antibodies and horseradish peroxidase (HRP)-
conjugated secondary antibodies (Amersham Biosciences), 1:5000. Detection was 
performed with luminol (Santa Cruz). For immunoprecipitations, hippocampal 
lysates were incubated with Protein A-Sepharose beads (Amersham) 
preconjugated with an anti-EphA4 antibody (serum 1383). Western blots were 
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quantified using ImageJ software. Optical density values were normalized to 
tubulin signal. Glutamate transporter proteins tend to form homomultimers (Haugeto 
et al., 1996). For GLAST a more prominent band of 120 kDa was quantified, 
probably corresponding to the dimeric form. For GLT1 a band of 70 kDa was 
quantified, corresponding to the monomeric form. 
 
4.2.3 Histology and image analysis 
 
Cardiac perfusion 
Mice were anaesthetised with an intraperitoneal injection of chloralhydrate (8% 
chloralhydrate, 0.9% NaCl in H2O). Skin and ribcage were cut open and the 
diaphragm was removed. A small incision was made into the right auriculum and a 
needle connected to a peristaltic pump was inserted into the left ventricle to 
replace the animal’s blood by cold PBS. This was followed by approximately 25 ml 
of cold 4% PFA solution for fixation. Brains or hippocampi were dissected out and 
postfixed overnight at 4 ºC in 4% PFA. 
 
Vibratome sections 
A layer of 2 ml embedding solution was poured into a small plastic mould and 
crosslinking was allowed by adding 100 l of 25% glutaraldehyde solution. The 
perfused and postfixed brains or hippocampi were placed on top and other 3.5 ml 
embedding solution with 175 l of glutaraldehyde was poured over them. The 
mould was left to set for 5 min at room temperature before cutting 40-60 m 
coronal sections with a vibratome. 
 
In situ hybridization analysis 
Vibratome sections were dehydrated in increasing concentrations of methanol in 
PBS and stored at –20 °C. After rehydration in decreasing concentrations of 
methanol in PBS, the slices were treated with proteinase K (20 μg/ml) in PBT and 
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postfixed for 20 min in 4% PFA, 0.2% glutaraldehyde. The sections were then 
prehybridized at 70 °C for 1 h in hybridization solution. Hybridization was carried 
out overnight at 60 °C in hybridization solution containing the digoxygenin-labeled 
riboprobe. The slices were then washed at 60 °C three times in solution 1, three 
times in solution 2 and three times in solution 3. After two washes at 70 °C in MABT, 
slices were incubated in blocking solution for 1.5 h at room temperature and then 
incubated overnight at 4 °C with an alkaline phosphatase-conjugated anti-
digoxygenin antibody (Roche) diluted 1:2000 in blocking solution. Slices were then 
washed 8-10 times with MABT and once in NTMT at room temperature. The signal 
was visualized by a color reaction using 500 l of developing solution. The reaction 
was allowed to develop in the dark at 4 °C and was stopped with PBT. The slices 
were postfixed with 4% PFA. 
 
Quantification of recombination efficiency 
Densitometric measurements of mRNA expression levels were performed using 
ImageJ software. Three equally sized areas were selected in CA1 and CA3 
pyramidal layer (red and blue squares in figure 2.3a, respectively) in every digital 
picture of Epha4 in situ hybridizations. The signal intensity values were corrected 
for background, determined as signal intensity in the stratum radiatum of CA1 
(yellow squares in figure 2.3a). The relative abundance of Epha4 mRNA was 
expressed as CA3/CA1 or CA1/CA3 ratios. The recombination efficiency was 
calculated as a ratio of CA1/CA3 values in CA1-cre;Epha4lx/– slices and CA1/CA3 
values in Epha4lx/– slices for CA1-cre;Epha4lx/– mice and as a ratio of CA3/CA1 
values in CA3-cre;Epha4lx/– and CA3/CA1 values in Epha4lx/– slices for CA3-
cre;Epha4lx/– mice. 
 
Immunofluorescence and immunohistochemistry 
For immunofluorescence, vibratome free-floating sections (50 μm thick) were 
permeabilized with 0.5% TritonX-100 in PBS, blocked in 0.1% TritonX-100, 5% 
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BSA and 5% donkey serum in PBS for 1 h at room temperature and incubated with 
primary antibodies overnight at 4 °C in blocking solution. The sections were washed 
three times for 30 min in PBS containing 0.1% Triton X-100 and incubated for 1 h 
at room temperature with donkey Cy2, Cy3 and Cy5-conjugated secondary 
antibodies (Jackson ImmunoResearch), diluted 1:800 in blocking solution. The 
sections were then mounted using aqueous mounting medium with antifading 
reagent (Biømeda). The Vectastain ABC kit (Vector Laboratories) was used for 
immunohistochemistry following provider’s instructions. 
 
4.2.4 Assessment of seizure susceptibility 
 
Mice were injected intraperitoneally with 45 mg per kg body weight PTZ, diluted 
in saline solution. After injection, mice were carefully monitored and videotaped.  
 
4.2.5 Electrophysiology 
 
Acute hippocampal slices preparation 
Mice (P40-80 for extracellular field recordings (EFRs), P12-24 for neuron patch-
clamp recordindgs and P18-24 for astrocyte patch-clamp recordings) were 
decapitated under diethylether anesthesia. Hippocampi were dissected in cold 
ACSF1 for EFRs and neuron patch-clamping and in ACSF2 for astrocyte patch-
clamping. Slices (400 m thick for EFRs and neuron patch-clamping and 300 m 
thick for astrocyte patch-clamping) were prepared using a custom made tissue 
slicer for EFRs or a vibratome for neuron and astrocyte patch-clamp recordings and 
maintained in ACSF1 or ACSF2 at room temperature for 1-2 h before recording. 
 
Extracellular field recordings 
Acute hippocampal slices were perfused with ACSF1 during recordings. Input-
output relations were measured at 25 °C. All the other experiments were 
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performed at 33 °C. Synaptic responses were evoked by stimulating Schaffer 
collaterals with 0.2 ms pulses using monopolar tungsten electrodes. Field excitatory 
postsynaptic potentials (fEPSPs) were recorded in the stratum radiatum of CA1 
region using glass microelectrodes filled with 3 M NaCl (resistance 5-15 MΩ). For 
baseline recordings, slices were stimulated at 0.1 Hz for 20 min at stimulation 
intensities of 40-50 % of the highest measured fEPSP size. LTP was induced by 
applying one tetanus (100 Hz for 1 s) or a theta-burst stimulation (TBS) consisting 
of three bursts (10 s interval), each composed of ten trains (5 Hz) with four pulses 
(100 Hz). Paired pulse facilitation (PPF) was tested by applying two pulses with 
inter-stimulus intervals (ISI) ranging from 10 ms to 160 ms. An Axoclamp 2B 
amplifier (Axon Instruments) was used for the experiments. Data were sampled at 
5 kHz and analyzed using a program written in LabView (National Instruments). All 
measurements were carried out and analyzed by an investigator blind to the 
genotype. 
 
Neuron patch-clamp recordings 
Recordings were performed at 33 °C. Borosilicate patch pipettes (resistance 2-7 
MΩ) were filled with internal solution 1. Pyramidal cells were visually identified by 
using a microscope with transmitted infrared light (Olympus BX51WI) connected to 
an infrared camera (Till Photonics). Spontaneous miniature excitatory post synaptic 
currents (mEPSCs) were recorded in whole-cell configuration at –70 mV. mEPSCs 
were recorded first in ACSF1 containing 100 μM picrotoxin (PTX) and 200 nM 
tetrodotoxin (TTX) and then in ACSF1 containing PTX, TTX and 1 mM –DGG. 
AMPAR and NMDAR currents in CA1 pyramidal cells were evoked by stimulating 
Schaffer collaterals with a monopolar tungsten electrode. The experiments were 
performed in ACSF1 containing 100 μM PTX. AMPAR currents were recorded in 
voltage-clamp mode at a membrane potential of −70 mV and peak amplitudes of 
the currents were measured. NMDAR currents were recorded at +40 mV and 
measured 70 ms after stimulus to avoid the initial mixed AMPAR/NMDAR 
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component. A Digidata 1440A digitizer and a Multiclamp 700B (both from Axon 
Instruments) were used for the experiments. Data were collected and analyzed 
using pCLAMP 10 Software (Axon Instruments). All measurements were carried out 
and analyzed by an investigator blind to the genotype. 
 
Astrocyte patch-clamp recordings 
Astrocyte patch-clamp recordings were performed at 24-26 °C with an EPC10 
Double amplifier (HEKA Electronics). Glass pipettes (resistance 2-4 MΩ) were filled 
with intracellular solution 2. During experiments, slices were perfused with ACSF2 
containing 20 μM bicuculline and 2.5 mM kynurenic acid to suppress activation of 
ionotropic glutamate as well as GABAA receptors. Astrocytes were held in voltage-
clamp mode at a membrane potential of −85 mV. Recordings were discarded 
when the series resistance exceeded 17 MΩ. Astrocytes were identified based on 
their membrane potential close to –85 mV, their high capacitance, low membrane 
resistance and passive current-voltage relationship upon application of 
depolarizing current pulses. Schaffer collaterals were stimulated with a tungsten 
concentric bipolar electrode (pulse duration 0.1 ms). Currents were corrected for 
the slow current insensitive to the glutamate transporter blockers L-trans-
pyrrolidine-2,4-dicarboxylic acid (PDC, 300 μM) and dihydrokainic acid (DHK, 
300 μM), likely reflecting accumulation of extracellular potassium. Extracellular 
field potentials for fiber volley detection were recorded with ACSF2-filled glass 
microelectrodes at a maximal distance of 50 μm from the recorded astrocyte. The 
stimulation intensity was adjusted such that fiber volley amplitudes were between 
−0.15 and −0.4 mV. For each stimulation intensity, 5-10 (single pulse experiments) 
or 3 (TBS) recordings were averaged. Data were collected at 10 KHz and were 
analyzed with IgorPro (Wavemetrics). All measurements were carried out and 
analyzed by an investigator blind to the genotype. 
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4.2.6 Statistical analysis 
 
Statistical significance was determined using two-tailed Student’s t-tests in Microsoft 
Excel, two-way analysis of variance (ANOVA) with repetitions using the software 
Statistics (Blackwell Scientific Publications), analysis of covariance (ANCOVA) from 
the VasserStats statistical computations website 
(http://faculty.vassar.edu/lowry/VassarStats.html) and two-sample Kolmogorov-
Smirnov tests using the Statistics to Use website 
(http://www.physics.csbsju.edu/stats/KS-test.html; T.W. Kirkman, 1996). The Mann-
Whitney U-test was performed using SPSS software (release 11.0; SPSS Inc.). All 
values in the text and in the figure legends indicate mean ± s.e.m. All error bars in 
the graphs represent s.e.m. 
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